Benign neoplasm of colon, rectum, anus and anal canal

CD2_BENIGN_COLORECANI

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12 Cause of death: ICD-10 — D12 2 out of 7 registries used, show all original rules.	29466
4. Check minimum number of events None	29466
5. Include endpoints CD2_BENIGN_COLON CD2_BENIGN_RECTOSIGMOID_JUNC CD2_BENIGN_RECTUM_ANAL	29966
6. Filter based on genotype QC (FinnGen only)	29966

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum intestini crassi

NAME	CD2_BENIGN_COLORECANI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_COLON\|CD2_BENIGN_RECTOSIGMOID_JUNC\|CD2_BENIGN_RECTUM_ANAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D12
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D12
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of colon, rectum, anus and anal canal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	166694	83081	82674
Only index persons	152318	77591	74727
Unadjusted period prevalence (%)
Whole population	2.34	2.38	2.31
Only index persons	2.85	2.85	2.85
Median age at first event (years)
Whole population	66.20	66.21	66.18
Only index persons	65.73	65.73	65.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29966	14727	15239
Unadjusted period prevalence (%)	5.88	5.02	6.72
Median age at first event (years)	65.48	64.11	66.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
26121: Matched controls
238257

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJF32

NOMESCO Finland

Coloscopy

14.7

323.0

18423

33400

WX002

NOMESCO Finland

Sedation and analgesia

1.9

323.0

5729

30057

UJF30

NOMESCO Finland

Ileoscopy through colon

6.7

323.0

5517

9142

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

256.0

323.0

6180

288

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

323.0

3320

13948

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

44.8

323.0

516

107

P01AB01

ATC

metronidazole; oral, rectal

1.7

323.0

9840

62182

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

323.0

12471

79056

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.5

323.0

3110

8880

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

323.0

11465

44798

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

323.0

9886

51755

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

76.7

323.0

7367

1214

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

28.0

323.0

1872

654

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.4

323.0

1843

5146

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

5.2

323.0

9545

23701

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

323.0

3467

14241

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

323.0

2542

7917

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.4

323.0

5002

8481

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

323.0

4880

24156

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

323.0

3437

13406

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

137.8

323.0

2061

148

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

209.9

323.0

6338

363

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

559.9

323.0

8785

219

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

184.1

323.0

1250

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

323.0

8016

37032

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

170.4

323.0

3243

198

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

159.6

323.0

4254

290

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

323.0

5968

30965

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

151.4

323.0

3168

217

N02BE01

ATC

paracetamol; systemic, rectal

2.1

323.0

22454

177098

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.6

323.0

2232

6030

A02BC02

ATC

pantoprazole; systemic

1.9

323.0

17695

123557

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

569.0

323.0

906

B01AB05

ATC

enoxaparin; parenteral

1.7

322.7

8433

51004

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

318.7

2539

9317

K92.1

ICD-10 Finland

Melaena

3.2

317.9

1880

5693

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

7.5

316.3

793

984

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

578.2

306.1

314

UJH02

NOMESCO Finland

Anoscopy

3.6

304.4

1504

3966

JFA42

NOMESCO Finland

Endoscopic injection in colon

65.4

299.4

360

A02BC05

ATC

esomeprazole; systemic

1.6

293.9

10483

68855

J01DB01

ATC

cefalexin; oral

1.7

292.5

20340

159759

N02AX02

ATC

tramadol; systemic, rectal

1.6

280.4

11106

74708

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

272.9

3029

13153

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

270.2

5639

31383

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

21.3

269.8

416

181

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

269.5

7005

41775

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.7

262.0

646

780

A02BC03

ATC

lansoprazole; oral

1.7

250.9

7787

48651

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

247.1

3594

17476

R06.0

ICD-10 Finland

Dyspnoea

1.7

246.5

6568

39253

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

242.9

7189

44234

K62.1

ICD-10 Finland

Rectal polyp

9.1

242.6

539

548

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

4.3

240.8

957

2071

H02AB06

ATC

prednisolone; systemic

1.5

232.9

11718

82248

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

48.9

231.9

292

JN4BD

NOMESCO Finland

Extensive body CT

2.0

229.3

3230

15470

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.9

227.0

1557

5174

K63.5

ICD-10 Finland

Polyp of colon

6.9

225.7

599

806

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

223.1

4014

21061

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

105.5

222.5

252

UJG02

NOMESCO Finland

Proctoscopy

4.5

219.1

832

1720

C05AA08

ATC

fluocortolone; rectal, topical

1.9

215.2

3816

19891

S18

ICPC

Laceration/cut

1.5

215.2

10670

74148

R4110

NOMESCO Finland

Physiotherapy

1.6

213.7

6736

41866

C03CA01

ATC

furosemide; systemic

1.6

204.8

7888

51475

N03AX16

ATC

pregabalin; oral

1.6

203.8

5953

36156

J01MA02

ATC

ciprofloxacin; systemic

1.5

203.7

9890

68123

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

197.2

1552

5593

R03AC02

ATC

salbutamol; inhalant

1.5

196.6

12109

87618

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

4.3

195.7

788

1724

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

20.7

191.8

298

133

D01

ICPC

Abdominal pain/cramps general

2.1

191.8

2414

10980

C07AB07

ATC

bisoprolol; oral

1.5

187.9

12460

91206

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

186.9

15478

118517

A02BC01

ATC

omeprazole; systemic

1.6

185.7

7036

45482

21140

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Rectum

+∞

182.2

181

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

179.3

1036

3056

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

18.3

178.0

288

145

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

7.7

177.7

437

525

M79.6

ICD-10 Finland

Pain in limb

1.5

176.0

8386

56980

UJF92

NOMESCO Finland

Capsular endoscopy

4.5

174.8

664

1371

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

172.3

2080

9269

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

170.2

2270

10551

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

169.1

1383

5083

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

169.0

906

2528

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.7

168.8

797

2009

A07EC02

ATC

mesalazine; oral, rectal

2.5

167.9

1405

5230

WX110

NOMESCO Finland

Local anesthesy

1.4

166.9

15607

120972

AA1AD

NOMESCO Finland

CT of head and brain

1.6

165.6

6136

39242

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

164.9

10843

78440

M54.5

ICD-10 Finland

Low back pain

1.5

163.5

7297

48680

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

163.5

8460

58269

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

163.2

2768

14090

UKC02

NOMESCO Finland

Cystoscopy

1.7

162.8

4368

25686

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

161.2

5397

33631

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

159.4

7630

51618

J01CA04

ATC

amoxicillin; systemic

1.5

154.8

18700

151049

A06AD11

ATC

lactulose; oral

1.7

153.6

3768

21557

N06AX11

ATC

mirtazapine; oral

1.5

152.0

7272

49077

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.8

151.5

535

1024

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

150.0

4166

24663

G04CA02

ATC

tamsulosin; oral

1.5

149.3

6058

39396

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

148.5

6023

39155

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

147.1

3940

23080

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

143.7

3519

20085

J01AA02

ATC

doxycycline; systemic

1.4

142.7

19101

155751

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

141.7

3478

19856

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

141.6

4733

29343

SPAT1263

SPAT

Sampling

1.4

141.5

9850

71326

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

141.4

8155

56969

JFB30

NOMESCO Finland

Right hemicolectomy

4.4

140.5

543

1140

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

139.4

6059

39903

C10AA05

ATC

atorvastatin; oral

1.4

138.9

9927

72155

R53

ICD-10 Finland

Malaise and fatigue

1.6

137.6

4671

29038

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

5.9

137.6

411

648

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

267.6

137.3

145

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.6

135.8

1075

3869

G47.3

ICD-10 Finland

Sleep apnoea

1.5

133.6

4926

31207

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

133.6

1602

7091

A02BA02

ATC

ranitidine; systemic

1.5

131.8

4997

31844

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

131.2

994

3487

J01MA12

ATC

levofloxacin; systemic

1.6

131.1

4597

28762

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

130.8

2310

11869

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

5.1

130.4

441

805

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

128.3

4114

25164

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

128.2

3980

24150

K59.0

ICD-10 Finland

Constipation

2.2

128.0

1450

6254

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

127.7

1671

7666

JN4AD

NOMESCO Finland

Body CT examination

1.9

127.7

2030

10046

N05CF01

ATC

zopiclone; oral

1.4

127.5

7847

55231

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

127.3

5957

39712

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

126.6

8914

64282

C08CA01

ATC

amlodipine; oral

1.4

125.6

9114

66053

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

157.0

125.6

137

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

8.6

125.6

287

307

XKD00

NOMESCO Finland

Uroflowmetry

1.6

124.7

4203

26003

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

4.0

123.6

533

1241

ZXA00

NOMESCO Finland

Right side

1.4

122.8

6699

46000

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

121.7

11037

82959

C10AA01

ATC

simvastatin; oral

1.4

121.5

11482

86887

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.8

120.9

257

242

A10BA02

ATC

metformin; oral

1.4

120.4

6920

47962

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.8

119.8

844

2830

B01AA03

ATC

warfarin; systemic

1.5

119.5

5237

34354

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

119.2

5991

40427

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

118.9

1255

5235

R03BB04

ATC

tiotropium bromide; inhalant

1.7

118.6

2608

14358

K30

ICD-10 Finland

Functional dyspepsia

1.8

117.5

2347

12538

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

117.5

2253

11879

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

115.6

4429

28180

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

115.6

925

3344

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

115.3

935

3408

ZX120

NOMESCO Finland

Intravenous

1.8

115.0

2286

12188

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

114.6

3800

23363

J01DA01

ATC

[U] cefalexin; systemic

1.3

112.9

14528

114893

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

112.7

2123

11120

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

112.7

5571

37395

L01BC06

ATC

capecitabine; oral

2.5

111.8

978

3712

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

111.3

6586

45749

K51.5

ICD-10 Finland

Left sided colitis

3.1

111.3

658

1968

WX892

NOMESCO Finland

Monitored bed care

1.9

110.1

1870

9453

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

7.2

109.9

281

359

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

109.9

807

2777

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

109.4

3071

18085

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.1

109.4

282

365

D06

ICPC

Abdominal pain localized other

1.9

109.0

1726

8511

R42

ICD-10 Finland

Dizziness and giddiness

1.5

108.3

5135

34133

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

108.1

743

2455

XF402

NOMESCO Finland

ECG with work load test

1.6

107.1

2827

16368

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

106.3

9634

71859

A06AC51

ATC

ispaghula, combinations; systemic

2.1

106.1

1236

5387

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

105.8

3399

20696

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

105.7

4317

27792

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.6

105.5

287

401

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

105.3

3735

23287

T90

ICPC

Diabetes non-insulin dependent

1.4

104.3

5655

38554

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

104.3

5695

38881

R51.80

ICD-10 Finland

Headache

1.6

104.2

2808

16341

D11

ICPC

Diarrhoea

1.8

103.4

2033

10782

M25.5

ICD-10 Finland

Pain in joint

1.4

103.1

5944

40977

R01AD09

ATC

mometasone; nasal

1.3

103.0

9283

69072

SPAT1153

SPAT

Removal of sutures

1.4

102.9

7698

55570

H02AB07

ATC

prednisone; oral

1.6

102.7

3356

20511

D16

ICPC

Rectal bleeding

3.2

102.5

584

1702

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

102.1

5393

36556

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.4

101.8

393

825

I84

ICD-10 Finland

Hemorrhoids

2.7

101.6

752

2599

K64.0

ICD-10 Finland

First degree haemorrhoids

4.3

101.5

405

878

ZXA05

NOMESCO Finland

Left side

1.4

101.2

6158

42852

N03AX12

ATC

gabapentin; oral

1.5

101.0

3509

21752

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

100.0

7601

54946

J01FA06

ATC

roxithromycin; oral

1.3

99.6

9113

67862

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.8

97.7

663

2172

UJD02

NOMESCO Finland

Gastroscopy

2.1

97.3

1230

5546

R02

ICPC

Shortness of breath/dyspnoea

1.6

97.2

2736

16085

A07EA06

ATC

budesonide; oral, local oral

2.6

96.9

783

2845

L03

ICPC

Low back symptom/complaint

1.4

96.9

5077

34308

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

96.6

936

3740

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

96.1

2420

13802

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

96.1

2230

12428

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.1

96.0

398

895

WX402

NOMESCO Finland

General anaesthesia

1.5

95.4

3467

21693

L17

ICPC

Foot/toe symptom/complaint

1.4

95.3

5633

38912

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

95.1

1504

7402

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

94.8

3741

23838

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

9.6

94.5

202

193

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

94.0

14990

120684

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

93.2

795

2977

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

93.1

2700

15983

E0000UV

ATC

1.3

93.0

8407

62292

A98

ICPC

Health maint/preventive medicine

1.5

92.6

23497

203618

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

92.5

1151

5156

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

92.1

11027

85149

M48.0

ICD-10 Finland

Spinal stenosis

1.6

91.9

3011

18371

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

91.6

3278

20421

K57

ICD-10 Finland

Diverticular disease of intestine

3.0

90.7

574

1798

M04AA01

ATC

allopurinol; systemic

1.5

90.5

3219

20020

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

89.2

4637

31214

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

89.1

7558

55355

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

88.9

5103

34996

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

88.8

3839

24910

SPAT1301

SPAT

No procedures

1.3

87.4

7249

52874

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

87.3

2573

15279

R03BA02

ATC

budesonide; inhalant

1.5

86.9

3665

23646

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

86.8

3196

20016

K62.0

ICD-10 Finland

Anal polyp

4.5

86.7

323

655

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.5

86.6

325

664

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.4

86.6

800

3122

A10BH01

ATC

sitagliptin; oral

1.6

86.1

2315

13423

C01DA14

ATC

isosorbide mononitrate; oral

1.5

85.9

3908

25604

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

6.8

85.8

227

306

207

Kela drug reimbursment

Chronic arrhythmias

1.5

85.4

3633

23470

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

85.4

6768

48970

D18

ICPC

Change in faeces/bowel movements

2.9

84.2

552

1769

R05

ICD-10 Finland

Cough

1.4

84.2

4185

27890

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

84.2

5610

39435

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

84.1

11652

91372

R35

ICD-10 Finland

Polyuria

1.8

83.6

1516

7813

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

82.7

3349

21398

Z01.7

ICD-10 Finland

Laboratory examination

1.6

82.5

2349

13816

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.6

82.5

300

594

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

82.5

2524

15117

A04

ICPC

Weakness/tiredness general

1.6

82.5

2694

16394

A07EA02

ATC

hydrocortisone; rectal

2.8

81.1

564

1877

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

80.9

2429

14476

K02.1

ICD-10 Finland

Caries of dentine

1.3

80.8

11437

89745

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

80.8

2312

13612

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

80.4

8658

65440

J02AC01

ATC

fluconazole; systemic

1.3

80.0

7823

58304

UJF34

NOMESCO Finland

Left colonoscopy

5.2

79.9

262

464

J01FF01

ATC

clindamycin; systemic

1.4

79.8

5936

42424

SPAT1254

SPAT

Administration of medicine

1.5

79.1

3249

20803

L04AX01

ATC

azathioprine; systemic

2.1

79.1

937

4107

M03BX02

ATC

tizanidine; oral

1.3

78.9

13400

107546

R60.0

ICD-10 Finland

Localized oedema

1.6

78.4

2532

15356

G44.2

ICD-10 Finland

Tension-type headache

1.6

78.3

2536

15388

N06AX21

ATC

duloxetine; oral

1.6

78.2

2140

12444

R07.3

ICD-10 Finland

Other chest pain

1.6

78.2

2090

12082

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

34.4

78.2

105

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

78.2

1606

8607

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

78.0

13063

104572

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

131.1

77.9

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

77.9

3014

19049

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

77.6

3051

19349

C10AC01

ATC

colestyramine; oral

2.5

77.1

639

2355

N06AB04

ATC

citalopram; systemic

1.4

77.0

4565

31369

SPAT1104

SPAT

Monitoring of emergency patient

1.8

77.0

1550

8257

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.8

76.8

272

524

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.4

76.7

676

2574

R31

ICD-10 Finland

Unspecified haematuria

1.6

76.5

2386

14343

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

76.2

1055

4929

SPAT1262

SPAT

Handing over of treatment supplies

1.4

75.6

4251

28922

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

75.2

9840

76161

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.6

75.0

596

2146

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

74.9

1327

6780

N05BA04

ATC

oxazepam; oral

1.4

74.9

5263

37206

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

74.8

1364

7038

XF404

NOMESCO Finland

Ambulatory ECG

1.6

74.6

2160

12739

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

74.5

6628

48606

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

74.0

2619

16213

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

5.8

73.9

221

351

R19.4

ICD-10 Finland

Change in bowel habit

2.6

73.9

572

2030

Z71.8

ICD-10 Finland

Other specified counselling

1.4

73.8

4599

31848

WX320

NOMESCO Finland

Spinalanesthesy

1.4

73.7

5084

35815

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

73.4

1636

8981

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

73.4

1515

8129

130

Kela drug reimbursment

Malignant tumour

1.6

73.4

1986

11509

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.9

73.4

484

1559

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

73.0

792

3337

J45

ICD-10 Finland

Asthma

1.6

72.9

1944

11219

H02AB04

ATC

methylprednisolone; systemic

1.5

72.7

3184

20633

C09CA01

ATC

losartan; oral

1.3

72.6

5646

40529

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

72.4

1681

9339

A02BC04

ATC

rabeprazole; oral

1.7

71.2

1743

9825

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

71.1

1033

4914

A11

ICPC

Chest pain NOS

1.7

71.0

1691

9461

C03DA01

ATC

spironolactone; oral

1.5

71.0

2494

15405

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

70.9

3837

25891

B01AF02

ATC

apixaban; oral

1.5

70.5

2321

14119

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

70.5

4962

35031

A01

ICPC

Pain general/multiple sites

1.7

70.4

1635

9079

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

22.0

70.3

106

B82

ICPC

Anaemia other/unspecified

2.5

70.0

597

2234

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

70.0

2337

14263

R11

ICD-10 Finland

Nausea and vomiting

1.7

69.8

1596

8824

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

4.0

68.9

288

654

R03AC03

ATC

terbutaline; inhalant

1.5

68.7

2826

18055

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

54.9

68.6

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.4

68.0

356

976

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

68.0

1707

9690

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

67.7

8581

65868

JG1CG

NOMESCO Finland

Extensive MRI of rectum

5.5

67.6

209

346

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

67.4

7431

55991

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

67.0

3107

20340

B01AB10

ATC

tinzaparin; parenteral

1.7

66.9

1553

8620

R06AE07

ATC

cetirizine; oral

1.3

66.9

8758

67473

M10.9

ICD-10 Finland

Gout, unspecified

1.7

66.7

1526

8434

SPAT1097

SPAT

Recording of ECG

1.4

66.7

3473

23241

3AC01

NOMESCO Finland

3.9

66.7

294

701

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

4.4

66.5

255

534

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

6.0

66.5

193

296

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

66.4

2173

13189

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

66.4

547

2008

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

66.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

66.4

1668

9466

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

66.3

572

2152

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

65.9

879

4047

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.9

65.7

423

1340

R13

ICD-10 Finland

Dysphagia

1.7

65.6

1445

7897

R52.9

ICD-10 Finland

Pain, unspecified

1.6

65.4

1724

9909

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

65.4

2144

13017

JG1BG

NOMESCO Finland

MRI of rectum

4.9

65.3

226

426

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

65.1

3456

23203

G04CA01

ATC

alfuzosin; oral

1.5

65.0

2727

17487

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

64.9

6641

49475

WZA90

NOMESCO Finland

Other doctors statement

1.4

64.9

4511

31721

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

64.6

2157

13149

SPAT1325

SPAT

Vaccination

1.3

64.6

7908

60329

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

64.4

A07AA02

ATC

nystatin; oral

1.7

64.3

1430

7838

D07AC01

ATC

betamethasone; topical

1.3

63.7

7406

56094

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.9

63.5

406

1282

R50.9

ICD-10 Finland

Fever, unspecified

1.5

63.3

2830

18373

R03DC03

ATC

montelukast; oral

1.4

63.2

3016

19833

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

63.1

2379

14904

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

63.0

788

3532

N05CF02

ATC

zolpidem; oral

1.4

62.7

3530

23937

M02AA07

ATC

piroxicam; topical

1.3

62.6

8409

64844

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

62.5

1997

12043

A03FA02

ATC

cisapride; oral, rectal

1.6

62.5

1770

10361

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

62.4

4661

33129

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

62.1

6080

44964

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

62.0

3523

23921

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

62.0

3372

22715

D12

ICPC

Constipation

2.1

62.0

761

3385

B01AC04

ATC

clopidogrel; oral

1.4

61.6

3761

25856

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

61.6

1120

5768

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

61.5

5333

38756

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

61.5

5668

41553

A28

ICPC

Limited function/disability NOS

1.4

61.4

3454

23410

R01AD08

ATC

fluticasone; nasal

1.3

61.3

5555

40623

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

61.3

3831

26443

K78

ICPC

Atrial fibrillation/flutter

1.6

61.2

1844

10963

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.2

61.2

339

971

A10BH05

ATC

linagliptin; oral

1.8

61.1

1132

5860

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

61.1

5219

37836

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

61.1

1539

8736

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

61.0

1510

8529

J20

ICD-10 Finland

Acute bronchitis

1.6

60.9

1920

11542

N06AX16

ATC

venlafaxine; oral

1.5

60.7

2440

15493

WX722

NOMESCO Finland

PEEP

1.8

60.6

1078

5507

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

60.5

3730

25682

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.5

60.4

507

1882

L01

ICPC

Neck symptom/complaint

1.5

60.4

2619

16887

SPAT1312

SPAT

General health counselling

1.3

60.4

6596

49473

N17

ICPC

Vertigo/dizziness

1.5

60.4

2339

14734

M79.1

ICD-10 Finland

Myalgia

1.5

60.3

2411

15292

D02

ICPC

Abdominal pain epigastric

1.8

60.1

1117

5790

R15

ICD-10 Finland

Faecal incontinence

2.2

60.0

618

2544

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

59.6

4405

31229

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

59.3

3695

25475

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

59.2

1977

12041

A10AE04

ATC

insulin glargine; parenteral

1.5

58.8

2009

12299

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

58.8

2266

14252

J01FA10

ATC

azithromycin; systemic

1.2

58.8

11613

93459

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

58.3

2274

14337

2114X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[NEOPLASMA BENIGNUM ALIUD RECTI ET CANALIS ANALIS]

+∞

58.3

JF2BD

NOMESCO Finland

Extensive colon CT

3.5

58.3

289

761

G04BD12

ATC

mirabegron; oral

1.5

58.2

2304

14573

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

6.6

58.2

157

219

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

58.1

1398

7832

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

58.1

1338

7404

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

58.1

3391

23112

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

57.6

2581

16741

N30.0

ICD-10 Finland

Acute cystitis

1.4

57.5

2743

18013

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

57.4

6432

48339

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

57.4

2823

18650

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

57.2

2905

19303

WX290

NOMESCO Finland

Other blockade of nerve

1.3

57.1

7844

60469

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

56.9

11456

92261

D64.8

ICD-10 Finland

Other specified anaemias

2.7

56.8

406

1375

M01AE02

ATC

naproxen; oral, rectal

1.2

56.8

11967

96851

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

56.7

14707

121730

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

56.5

9475

74744

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

56.4

506

1947

J01MA14

ATC

moxifloxacin; systemic

1.5

55.9

1876

11436

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

55.8

3604

24969

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

4.7

55.6

197

382

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

55.5

1875

11443

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

55.5

1364

7685

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

55.4

2222

14084

JFF23

NOMESCO Finland

Transversostomy

3.3

55.3

299

842

J01EA01

ATC

trimethoprim; systemic

1.3

55.2

5209

38219

R96

ICPC

Asthma

1.6

55.1

1754

10560

M01AH05

ATC

etoricoxib; oral

1.2

55.0

12670

103377

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

54.9

916

4579

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

54.8

3231

22036

Z93.3

ICD-10 Finland

Colostomy status

3.9

54.6

235

550

205

Kela drug reimbursment

Chronic hypertension

1.3

54.4

6855

52212

SPAT1216

SPAT

Assessment of functional ability

1.4

54.3

3460

23911

A46

ICD-10 Finland

Erysipelas

1.4

54.3

3072

20805

B80

ICPC

Iron deficiency anaemia

2.6

54.2

420

1493

ZXA10

NOMESCO Finland

Bilateral

1.3

53.9

4080

28973

-60

ICPC

Result test/procedure

1.7

53.5

1253

6967

JAH01

NOMESCO Finland

Laparoscopy

1.9

53.4

819

3972

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.7

53.4

161

260

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

53.4

9026

71125

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

53.3

1605

9530

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

53.2

1487

8665

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

53.2

1581

9360

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

53.2

4785

34847

S29

ICPC

Skin symptom/complaint other

1.4

53.2

3483

24171

C10AA07

ATC

rosuvastatin; oral

1.3

53.1

5494

40784

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

53.1

883

4410

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

53.0

3881

27412

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

53.0

5748

42934

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

4.4

52.6

199

413

C09AA05

ATC

ramipril; oral

1.3

52.5

5821

43588

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

52.4

1577

9363

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

52.2

2259

14538

M01AB05

ATC

diclofenac; systemic, rectal

1.2

52.0

14882

123863

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

4.1

52.0

213

477

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

52.0

3614

25314

JFB43

NOMESCO Finland

Left hemicolectomy

4.3

51.8

204

440

Z01.2

ICD-10 Finland

Dental examination

1.2

51.6

7870

61230

K29.8

ICD-10 Finland

Duodenitis

3.5

51.5

253

662

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

51.4

525

2153

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

51.2

1641

9889

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

51.2

1892

11779

KMAK

NOMESCO Finland

1.2

51.0

10205

81771

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

51.0

1383

7993

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

50.9

6273

47567

J01FA09

ATC

clarithromycin; systemic

1.3

50.9

6258

47440

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

50.8

1299

7395

A10BB12

ATC

glimepiride; oral

1.5

50.7

1671

10136

R03BA05

ATC

fluticasone; inhalant

1.4

50.6

3480

24320

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

50.5

939

4868

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

50.4

1234

6939

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

50.4

2257

14622

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

50.4

5023

37063

2114C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA TUBULARE RECTI ET CANALIS ANALIS]

+∞

50.3

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

50.3

1912

11974

N06AB10

ATC

escitalopram; oral

1.4

50.2

3378

23523

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

50.1

1180

6568

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

50.1

2702

18121

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

50.0

20677

178682

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

49.6

7801

60834

M54

ICD-10 Finland

Dorsalgia

1.5

49.6

2026

12878

K60.1

ICD-10 Finland

Chronic anal fissure

2.3

49.6

464

1825

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.0

49.6

301

921

SPAT1053

SPAT

Memory test

1.3

49.6

3527

24777

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

49.5

1014

5415

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

49.5

8241

64671

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.3

49.4

474

1887

E000001

ATC

1.3

49.3

3938

28147

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

49.3

1697

10395

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

49.3

R03BA01

ATC

beclometasone; inhalant

1.4

49.0

2843

19312

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.5

49.0

420

1578

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

48.8

1405

8247

A11CC03

ATC

alfacalcidol; systemic

2.2

48.5

522

2192

R33

ICD-10 Finland

Retention of urine

1.5

48.3

1742

10779

EBA00

NOMESCO Finland

Extraction of tooth

1.3

48.2

6423

49106

N06AA09

ATC

amitriptyline; systemic

1.4

48.0

2144

13875

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

47.8

1188

6711

R19.5

ICD-10 Finland

Other faecal abnormalities

2.8

47.6

330

1098

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

47.5

1841

11569

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

47.5

703

3368

S21

ICPC

Skin texture symptom/complaint

1.4

47.5

2523

16866

J01MA06

ATC

norfloxacin; oral

1.4

47.5

2779

18896

I50.0

ICD-10 Finland

Congestive heart failure

1.5

47.4

1608

9813

N01

ICPC

Headache

1.6

47.3

1435

8530

L05

ICPC

Flank/axilla symptom/complaint

1.7

47.3

1082

5970

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

47.3

4827

35680

TK800

NOMESCO Finland

Hemodialysis

2.2

47.3

485

1993

K96

ICPC

Haemorrhoids

2.2

47.3

485

1993

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

4.6

47.2

172

344

M01AX17

ATC

nimesulide; oral

1.3

47.2

5512

41456

U02

ICPC

Urinary frequency/urgency

1.4

47.1

2557

17159

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

46.6

2451

16354

H25.8

ICD-10 Finland

Other senile cataract

1.4

46.5

2464

16457

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

46.5

1064

5869

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

46.5

3649

25994

L08

ICPC

Shoulder symptom/complaint

1.3

46.3

3918

28219

K50.8

ICD-10 Finland

Other Crohn disease

2.9

46.2

297

944

D75

ICPC

Malignant neoplasm colon/rectum

3.7

46.1

209

513

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

46.0

2458

16439

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.2

45.9

511

2180

L15

ICPC

Knee symptom/complaint

1.3

45.6

4246

30986

N19

ICD-10 Finland

Unspecified kidney failure

1.9

45.4

745

3704

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

45.3

1253

7276

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

7.1

45.3

115

148

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

45.2

1581

9712

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

45.2

1133

6413

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

45.1

1524

9288

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

44.8

3966

28728

C08CA13

ATC

lercanidipine; oral

1.4

44.8

2919

20194

C07AB02

ATC

metoprolol; systemic

1.3

44.5

4801

35701

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

44.5

625

2937

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

44.4

2079

13569

A08

ICPC

Swelling

1.7

44.4

883

4675

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

44.3

934

5033

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

44.3

1275

7480

R05

ICPC

Cough

1.3

44.3

4308

31605

N02AA05

ATC

oxycodone; systemic

1.3

44.3

3201

22508

K51.8

ICD-10 Finland

Other ulcerative colitis

2.9

44.2

288

923

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.3

44.1

434

1750

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

44.1

1035

5755

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.5

44.0

218

576

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

44.0

901

4812

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

43.8

1166

6704

ICD-10 Finland

2.1

43.8

529

2337

L13

ICPC

Hip symptom/complaint

1.3

43.8

3335

23631

K58

ICD-10 Finland

Irritable bowel syndrome

2.3

43.7

415

1643

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

43.6

1348

8047

-50

ICPC

Medication/prescr/renewal

1.7

43.6

888

4736

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.3

43.5

420

1679

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

43.3

1589

9861

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

4.1

43.3

176

393

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

43.3

3419

24354

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

43.2

1697

10686

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.5

43.2

1463

8921

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

43.2

1422

8615

C10AX09

ATC

ezetimibe; oral

1.4

43.2

2379

15991

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.8

43.1

149

283

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

42.9

1418

8599

C09CA06

ATC

candesartan; oral

1.3

42.8

4449

32909

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

42.6

837

4414

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

42.5

741

3759

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

42.5

945

5173

R05FB02

ATC

cough suppressants and expectorants

1.2

42.4

8369

66570

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.7

42.4

149

288

SPAT1260

SPAT

Consultation of another employee

1.3

42.3

3697

26706

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

42.3

1173

6819

SPAT1285

SPAT

Provision of consultation response

1.6

42.1

1099

6288

M01AX05

ATC

glucosamine; oral

1.3

42.0

4673

34850

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

42.0

1893

12257

C07AA05

ATC

propranolol; systemic

1.3

41.7

3513

25243

L16

ICPC

Ankle symptom/complaint

1.4

41.7

1829

11781

SPAT1255

SPAT

Intravenous administration of medicine

1.5

41.5

1364

8256

N05AH04

ATC

quetiapine; oral

1.4

41.5

2777

19273

S82

ICPC

Naevus/mole

1.4

41.3

2287

15379

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

41.3

8600

68722

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

5.2

41.2

134

238

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

41.1

967

5375

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

41.1

2840

19811

S97

ICPC

Chronic ulcer skin

1.6

41.1

1149

6691

R04.0

ICD-10 Finland

Epistaxis

1.5

41.0

1529

9521

R74

ICPC

Upper respiratory infection acute

1.3

41.0

4349

32228

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

40.9

418

1716

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

40.9

1339

8100

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

40.9

1090

6272

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

24.5

40.7

L28

ICPC

Limited function/disability (L)

1.3

40.7

3380

24232

X58

ICD-10 Finland

Exposure to other specified factors

1.4

40.5

2421

16495

K62.3

ICD-10 Finland

Rectal prolapse

2.7

40.4

296

1021

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

40.4

899

4923

SPAT1310

SPAT

Counselling related to known health issue

1.2

40.3

6625

51640

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

40.3

822

4385

K22.7

ICD-10 Finland

Barrett oesophagus

2.6

40.1

308

1091

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.7

39.9

280

941

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.7

39.9

289

991

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

39.8

4777

35931

L14

ICPC

Leg/thigh symptom/complaint

1.5

39.8

1454

9014

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

39.8

672

3376

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

39.8

1559

9814

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

39.7

1023

5833

R03AC13

ATC

formoterol; inhalant

1.6

39.6

1006

5711

U05

ICPC

Urination problems other

1.7

39.6

947

5292

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.2

39.6

220

635

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

39.6

5328

40614

G04BD08

ATC

solifenacin; oral

1.5

39.5

1445

8961

AN1

Coronary angiography

1.3

39.5

2719

18949

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.2

39.4

433

1839

JAH00

NOMESCO Finland

Laparotomy

1.9

39.4

565

2677

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

39.4

4942

37362

Z50.1

ICD-10 Finland

Other physical therapy

1.6

39.4

1127

6600

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

39.3

337

1271

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

39.1

666

3354

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

5.0

39.1

130

237

R06AX27

ATC

desloratadine; oral

1.3

39.0

4544

34039

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

39.0

2331

15878

P20

ICPC

Memory disturbance

1.3

38.9

2675

18632

A01AB09

ATC

miconazole; local oral

1.4

38.7

1781

11570

SFA00

NOMESCO Finland

Small filling

1.4

38.5

2341

15991

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

38.4

1536

9704

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

38.4

710

3674

A02BDXX

ATC

1.7

38.2

799

4294

E66.8

ICD-10 Finland

Other obesity

1.7

38.1

817

4425

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

38.0

1250

7568

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

5.5

38.0

116

192

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

38.0

1937

12832

B01AB04

ATC

dalteparin; parenteral

1.6

37.9

1011

5816

D50

ICD-10 Finland

Iron deficiency anaemia

2.4

37.9

331

1260

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

37.9

749

3959

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

37.8

2526

17511

A02BA04

ATC

nizatidine; systemic

1.4

37.8

1688

10904

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

37.7

3579

26111

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

5.0

37.6

125

228

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

37.6

2057

13798

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

7.7

37.5

107

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.5

37.4

302

1102

R10.0

ICD-10 Finland

Acute abdomen

1.9

37.3

579

2823

N06AB06

ATC

sertraline; oral

1.4

37.3

1766

11536

WW500

NOMESCO Finland

Blood transfusion

1.7

37.2

788

4250

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

37.2

1222

7394

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

37.1

1194

7192

C02AC05

ATC

moxonidine; oral

1.6

37.1

971

5557

R03BA08

ATC

ciclesonide; inhalant

1.5

37.0

1483

9374

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

37.0

2070

13932

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

37.0

1233

7487

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

37.0

1029

5985

R4190

NOMESCO Finland

Nutritional therapy

1.9

36.9

555

2674

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

36.9

2594

18125

R04.2

ICD-10 Finland

Haemoptysis

1.8

36.9

716

3760

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

36.8

1361

8455

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

36.8

1946

12971

K92.0

ICD-10 Finland

Haematemesis

2.0

36.8

502

2331

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.2

36.7

391

1637

H26.4

ICD-10 Finland

After-cataract

1.4

36.7

1956

13054

WX882

NOMESCO Finland

High dependency care

1.9

36.7

551

2654

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

18.3

36.6

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

36.6

1170

7038

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

36.5

918

5201

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

36.4

1108

6589

UJF02

NOMESCO Finland

Peroral enteroscopy

3.7

36.2

164

404

N05BA01

ATC

diazepam; systemic, rectal

1.3

36.0

2671

18810

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

4.7

35.7

125

242

I20.09

ICD-10 Finland

Unstable angina

1.5

35.6

1236

7573

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

35.6

306

1155

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

35.6

1823

12078

R4120

NOMESCO Finland

Occupational therapy

1.5

35.5

1181

7166

R55

ICD-10 Finland

Syncope and collapse

1.4

35.5

2219

15215

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

35.5

1572

10138

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

35.4

1431

9057

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

35.4

663

3447

JHA00

NOMESCO Finland

Anal or perianal incision

2.7

35.4

260

900

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18754

137637

1.61

321.74

4.0

3.1

u/l

58.7

52.7

10.42

17392

126514

(3015736) pH of Urine

12589

84365

1.60

314.61

4.4

3.5

5.6

5.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10844

70168

1.62

313.15

3.7

3.2

u/l

34.6

34.9

0.08

10184

66217

(3015377) Calcium [Moles/volume] in Serum or Plasma

11872

78553

1.60

312.31

3.7

3.4

mmol/l

2.4

2.63

10108

67765

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4314

21529

1.94

309.83

2.6

2.1

g/l

0.2

8.20

4034

19877

(3006315) Basophils [#/volume] in Blood

16877

110200

1.87

307.65

6.8

5.7

e9/l

0.0

0.19

14583

94319

(3018095) Leukocytes [#/volume] in Urine

12313

81376

1.62

307.65

4.6

3.7

e6/l

81.2

113.4

5.34

9010

58622

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11375

72380

1.67

307.65

3.4

3.0

ng/l

1701.3

1504.0

3.30

9927

62321

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2650

10730

2.35

307.65

1.7

1.6

g/l

1.6

0.09

2292

9072

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6532

24138

2.84

307.65

4.5

3.9

ug/l

17.3

28.1

1.29

5456

19685

(3002030) Lymphocytes/100 leukocytes in Blood

15712

105830

1.71

307.65

7.2

6.1

26.3

27.1

16.72

14600

97920

(3013115) Eosinophils [#/volume] in Blood

17306

113542

1.89

307.65

7.0

5.9

e9/l

0.2

2.11

15142

98624

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4277

20230

2.06

307.65

2.8

2.4

u/l

45.7

47.4

0.08

3670

17230

(3014576) Chloride [Moles/volume] in Serum or Plasma

5739

29898

1.91

307.65

7.6

6.9

mmol/l

104.4

104.3

0.88

5639

29199

(3048689) Calprotectin [Mass/mass] in Stool

5789

21945

2.71

307.65

2.4

2.1

ug/g

146.8

145.7

0.06

4628

16955

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6588

31285

2.15

307.65

3.2

2.5

20.7

22.5

19.83

5698

26390

(3019198) Lymphocytes [#/volume] in Blood

17085

112352

1.87

307.65

6.8

5.8

e9/l

1.9

2.10

14988

97860

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7037

39971

1.77

307.65

3.2

2.8

e6/l

1.1

1.2

0.37

4253

22936

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

18966

119590

2.17

307.65

7.1

6.2

umol/l

11.4

11.8

4.35

18112

113245

(3013826) Glucose [Moles/volume] in Serum or Plasma

19307

135617

1.80

307.65

6.0

4.7

mmol/l

6.9

6.8

3.99

18331

127477

(3044640) Blood type and Crossmatch panel - Blood

11977

71268

1.86

307.65

2.9

2.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

16845

100845

2.16

307.65

6.1

4.7

g/l

35.0

0.23

15847

92959

(3007164) IgA [Mass/volume] in Serum or Plasma

7148

36497

2.01

307.65

1.5

g/l

2.6

0.71

4001

21497

(42870588) Differential panel, method unspecified - Blood

12355

76455

1.78

307.65

6.5

5.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12342

71588

1.94

307.65

3.0

2.5

u/l

58.7

59.0

0.19

11486

65624

(3013650) Neutrophils [#/volume] in Blood by Automated count

18998

127575

1.94

307.65

10.0

9.1

e9/l

4.2

2.99

16604

110800

(3013707) Erythrocyte sedimentation rate by Westergren method

22866

164991

2.06

307.65

5.1

4.1

mm/h

14.1

13.3

12.60

21224

151508

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9381

54330

1.81

307.65

2.8

2.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11076

56238

2.23

307.65

2.8

2.2

mg/l

3.3

3.0

20.81

9619

47596

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17616

118078

1.84

307.65

8.5

6.6

mmol/l

1.2

14.48

15488

98598

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

27353

218942

2.46

307.65

22.8

15.3

mg/l

25.7

25.2

1.64

23549

175654

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7977

41373

2.01

307.65

1.3

1.2

u/ml

1.8

1.7

0.14

1818

10815

(3023368) Bacteria identified in Blood by Culture

10563

65579

1.70

307.65

5.0

4.3

—

(3018010) Neutrophils/100 leukocytes in Blood

15563

104108

1.73

307.65

6.9

5.9

58.6

57.8

12.19

14487

96777

(40768797) Stomach Pathology biopsy report

7040

29995

2.46

307.65

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

15110

98204

1.78

307.65

11.3

9.6

inr

1.3

0.78

3385

27915

(3022145) Colonoscopy Study observation

10978

20107

7.20

307.65

1.5

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

9814

57563

1.80

307.65

5.2

3.9

87.9

88.2

0.47

9603

56152

(3006504) Eosinophils/100 leukocytes in Blood

15449

103070

1.73

307.65

7.0

6.0

2.8

2.9

2.91

14409

95552

(3022948) Iron [Moles/volume] in Serum or Plasma

7366

36015

2.12

307.65

3.1

2.5

umol/l

11.9

12.7

20.09

6897

33079

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3807

16713

2.21

307.65

1.7

1.6

—

(3019069) Monocytes/100 leukocytes in Blood

15513

103626

1.73

307.65

7.3

6.3

8.8

1.03

14506

96448

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5051

25179

1.97

307.65

3.1

2.7

umol/l

8.0

9.4

5.17

4439

21890

(40758558) Short blood count panel - Blood

9161

56103

1.68

307.65

7.5

6.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3133

12064

2.50

307.65

2.7

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

8080

45881

1.81

307.65

1.8

nmol/l

1121.5

1171.7

4.83

6172

34250

(3027945) Reticulocytes/100 erythrocytes in Blood

5450

26943

2.01

307.65

2.5

2.4

1.8

1.19

4805

23670

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6903

33399

2.12

307.65

3.1

2.4

g/l

2.3

12.69

6437

30664

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15816

104452

1.78

307.65

4.7

4.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15618

96747

1.95

307.65

2.4

2.0

pmol/l

94.8

95.0

0.27

8650

49516

(3001604) Monocytes [#/volume] in Blood

16789

109573

1.87

307.65

6.8

5.7

e9/l

0.6

0.44

14514

93738

(3021960) Folate [Moles/volume] in Serum or Plasma

9287

55223

1.75

307.65

1.7

1.5

nmol/l

20.6

20.4

0.51

8062

46651

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16373

107214

1.83

307.65

7.3

6.0

mmol/l

1.2

8.68

14987

96416

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14512

86882

1.98

307.65

3.7

2.7

ug/l

135.0

153.6

9.18

13448

79144

(3031040) Bacteria [#/volume] in Urine by Automated count

20921

148574

1.90

307.65

5.8

4.6

e6/l

525.8

1522.7

3.93

178

2373

(3037467) Urinalysis macro (dipstick) panel - Urine

21356

154231

1.87

307.65

5.5

4.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

24608

175573

2.48

307.65

9.8

7.6

u/l

80.0

79.6

0.58

23514

164530

(3022096) Basophils/100 leukocytes in Blood

15046

100202

1.71

307.65

7.0

6.0

0.7

0.19

14026

92959

(40768804) Tissue Pathology biopsy report

14831

89134

1.99

307.65

2.5

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

10160

65134

1.62

301.98

3.9

3.2

e6/l

0.4

0.13

7845

49236

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13365

91467

1.57

300.69

2.6

2.2

nmol/l

78.2

1093.3

0.50

11863

80839

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6477

37050

1.74

297.40

3.4

3.0

e6/l

2.5

0.18

3735

20176

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

25121

200413

1.81

296.77

5.6

4.7

mu/l

2.0

2.1

0.51

23068

181007

(3023520) Reticulocytes [#/volume] in Blood

4094

20358

1.94

296.08

2.6

e9/l

69.7

68.9

0.76

3135

15500

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13242

90919

1.56

290.11

4.6

3.7

ng/l

44.0

71.4

3.58

9880

66199

(3019550) Sodium [Moles/volume] in Serum or Plasma

27856

230631

2.28

288.09

26.6

17.8

mmol/l

139.6

139.7

4.27

27418

224680

(3023103) Potassium [Moles/volume] in Serum or Plasma

27871

231179

2.26

279.92

26.8

17.9

mmol/l

4.0

0.16

27404

224860

(36304419) Bacteria [Presence] in Urine

9736

62703

1.59

278.33

3.8

3.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8364

52029

1.62

275.54

4.6

3.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1772

6459

2.57

274.36

1.5

1.4

ug/g

272.3

264.0

0.90

1081

3775

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5073

27609

1.79

274.11

3.9

4.2

u/l

238.9

247.0

1.93

4765

26032

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21455

165400

1.60

272.33

4.4

4.0

pmol/l

15.0

14.9

1.46

19505

148453

(3002582) Erythrocytes [#/volume] in Urine

10741

71099

1.57

270.92

4.0

3.3

e6/l

77.4

103.9

1.20

8405

54764

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5089

27834

1.78

269.96

7.2

7.0

kpa

5.1

0.08

4857

26503

(3027801) Oxygen [Partial pressure] in Arterial blood

5084

27817

1.78

269.28

7.2

7.0

kpa

12.0

12.2

2.08

4841

26489

(3003396) Base excess in Arterial blood by calculation

5081

27801

1.78

269.09

7.2

7.0

mmol/l

0.9

1.1

2.34

4029

21986

(40761511) CBC panel - Blood by Automated count

27331

225706

2.05

265.25

21.7

14.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5457

30609

1.74

264.67

7.2

5.5

mmol/l

1.1

1.0

5.18

5092

28306

(3014765) Yersinia sp identified in Stool by Organism specific culture

1605

5726

2.62

259.30

1.3

1.2

—

(3000991) Gas panel - Venous blood

3850

19563

1.89

258.18

8.6

8.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

1604

5740

2.61

257.50

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2080

8403

2.33

256.92

3.5

3.3

u/ml

814.6

1617.6

0.92

1771

7194

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1586

5683

2.60

253.87

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

15099

108715

1.51

252.02

4.6

3.8

estimate

0.0

0.20

2050

20681

(3014111) Lactate [Moles/volume] in Serum or Plasma

3993

20755

1.85

248.68

7.0

6.7

mmol/l

1.3

1.4

0.80

3837

19989

(3026008) Bacteria identified in Urine by Culture

10602

70996

1.54

247.87

3.7

3.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

9414

61460

1.56

246.57

3.1

2.7

umol/l

4561.8

5097.5

0.59

8142

52478

(3042936) Bacteria identified in Isolate by Culture

5665

32683

1.70

245.89

2.2

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4128

21777

1.82

244.76

4.8

3.7

kpa

5.8

0.77

4003

21159

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7115

43578

1.62

244.34

3.5

3.1

mmol/l

2.5

0.36

6114

38037

(3009261) Glucose [Presence] in Urine by Test strip

15234

110352

1.50

243.44

4.7

3.8

estimate

0.0

0.03

2048

20454

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7619

47483

1.60

243.32

2.0

1.7

mg/l

1.3

0.83

5959

36901

(3016502) Oxygen saturation in Arterial blood

4572

24927

1.77

242.59

7.4

95.6

95.5

0.19

4434

23975

(3018418) pH of Serum or Plasma

10501

70437

1.53

242.10

5.1

4.1

7.4

0.69

1433

13821

(3002032) Base excess in Venous blood by calculation

4112

21756

1.82

241.21

4.8

3.7

mmol/l

1.8

1.9

1.80

3403

17788

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10737

72562

1.52

237.91

2.3

2.1

u/l

193.7

213.0

1.66

10081

67684

(3021601) Nitrite [Presence] in Urine by Test strip

15048

109072

1.49

237.18

6.3

5.0

estimate

0.0

0.07

2134

20975

(3012544) pH of Venous blood

4227

22671

1.79

236.61

4.8

3.7

7.4

0.57

124

(3026782) Osmolality of Urine

7397

46151

1.59

233.40

3.3

2.8

mosm/kgh2o

539.8

546.9

0.54

6140

39440

(3020779) Urea [Moles/volume] in Serum or Plasma

4003

21211

1.81

233.01

9.2

6.8

mmol/l

11.0

10.4

5.74

3788

20072

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

25402

206726

1.71

232.05

7.6

6.1

mmol/mol

41.0

40.3

22.10

23639

189008

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27870

233628

2.09

227.95

14.7

10.8

u/l

25.6

26.0

2.93

27177

224223

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4210

22818

1.77

226.58

7.9

7.8

g/l

119.0

121.1

9.18

4091

21991

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3452

17632

1.87

225.67

4.6

3.7

ng/l

102.4

91.7

7.85

3014

14934

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7351

46267

1.57

221.36

4.6

3.9

ng/l

519.0

485.6

0.10

6146

37696

(36660697) Celiac disease serology panel - Serum

3029

14973

1.92

218.58

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6274

38244

1.61

215.54

3.7

3.3

mmol/l

0.8

6.86

5845

35447

(3020564) Creatinine [Moles/volume] in Serum or Plasma

27815

233732

2.03

213.18

26.5

18.1

umol/l

84.3

79.7

53.77

27807

233629

(3024354) Oxygen [Partial pressure] in Venous blood

3423

17813

1.83

209.82

3.9

3.1

kpa

4.5

0.02

3304

17222

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6007

36530

1.60

207.27

2.3

2.0

30.1

29.9

2.04

5845

35439

(3000850) Epithelial cells [#/volume] in Urine

7702

49670

1.54

205.26

3.0

2.6

e6/l

4.6

5.1

3.30

6620

43542

(3022217) INR in Platelet poor plasma by Coagulation assay

5559

33266

1.62

204.59

32.5

25.8

inr

1.5

1.4

4.46

506

4804

(3020630) Protein [Mass/volume] in Serum or Plasma

3740

20265

1.76

199.44

2.5

2.6

g/l

66.0

66.4

2.39

3374

18300

(3009542) Hematocrit [Volume Fraction] of Blood

23812

192694

1.56

197.01

24.9

16.4

38.6

39.4

26.64

15658

129088

(3014007) Fractional oxyhemoglobin in Arterial blood

2979

15129

1.86

196.67

8.6

8.9

93.7

93.8

0.40

2971

15070

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6258

38855

1.57

196.14

2.0

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10948

76405

1.46

196.02

4.4

3.9

mg/mmol

11.9

8.7

8.12

7295

47442

(3003327) Ova and parasites identified in Stool by Light microscopy

1529

6066

2.34

195.57

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2768

13806

1.89

193.13

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1907

8373

2.13

190.51

1.4

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2948

15084

1.85

189.69

8.6

8.8

0.7

0.57

2934

14979

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2942

15133

1.84

185.91

8.5

8.7

1.4

0.79

2925

15021

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

25322

208704

1.61

183.56

20.3

14.5

ml/min/173m2

75.3

77.1

32.49

21609

172747

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

26027

216053

1.66

182.31

5.8

4.8

mmol/l

6.1

6.0

36.20

23925

194848

(3012516) Albumin [Mass/volume] in Urine

10381

72527

1.45

180.65

3.6

3.2

mg/l

527.7

405.6

1.56

6958

45253

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1970

8935

2.06

180.31

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

10600

74375

1.44

180.11

3.5

3.2

mmol/l

7.3

7.4

2.10

8905

61555

(3007853) Bacteria identified in Skin by Aerobe culture

4531

26520

1.64

179.75

2.0

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2237

10649

1.97

178.78

5.0

4.0

mmol/l

24.0

24.2

1.88

2013

9502

(3025941) Bacteria identified in Stool by Culture

2331

11307

1.93

176.21

1.4

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3151

16827

1.77

175.17

2.3

2.4

—

(3037522) Nuclear Ab [Titer] in Serum

4678

27911

1.61

170.77

1.4

1.3

titre

504.0

547.6

0.88

992

6025

(3007461) Platelets [#/volume] in Blood

28251

240937

2.01

169.60

34.4

22.4

e9/l

246.1

246.7

0.73

27771

233709

(3035941) MCH [Entitic mass]

28250

241026

2.01

167.66

34.2

22.3

30.3

30.4

9.09

27969

236920

(3024731) MCV [Entitic volume]

28252

241058

2.01

167.48

34.3

22.3

91.5

91.4

1.23

27971

236942

(3026361) Erythrocytes [#/volume] in Blood

28252

241071

2.00

167.23

34.4

22.4

e12/l

4.4

4.5

105.06

27681

232933

(3044889) 12 lead EKG panel

20221

160186

1.43

167.07

4.8

4.0

—

(3010813) Leukocytes [#/volume] in Blood

28253

241099

2.00

166.92

34.4

22.4

e9/l

6.9

6.8

18.12

27683

233019

(3000963) Hemoglobin [Mass/volume] in Blood

28254

241115

2.00

166.83

34.6

22.5

g/l

131.8

134.8

193.31

27977

237020

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4486

26653

1.61

166.19

1.9

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2507

12721

1.85

164.51

8.7

8.9

mmol/l

24.2

24.4

2.06

2326

11810

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1816

8370

2.02

158.46

3.1

2.9

u/ml

0.3

0.4

3.56

1035

4804

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4450

26663

1.59

158.41

2.0

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26463

222121

1.64

157.20

6.0

5.2

mmol/l

2.6

2.7

74.76

24505

202223

(3019150) Specific gravity of Urine by Refractometry

7170

47693

1.47

156.55

5.3

4.2

kg/l

1.0

0.50

1121

7288

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1621

7280

2.07

151.68

1.7

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3703

21483

1.63

149.80

2.5

2.3

ug/l

6.1

7.4

3.91

3186

18604

(3013512) EKG study

9869

70113

1.40

148.45

4.9

4.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15290

116740

1.37

147.90

2.7

2.5

—

(40761535) Cells panel - Urine sediment

3413

19500

1.65

146.45

4.3

3.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

25022

208177

1.51

144.31

4.7

4.1

mmol/l

1.4

1.3

25.65

22809

187718

(3020961) Endomysium IgA Ab [Titer] in Serum

1744

8219

1.97

142.49

1.1

titre

215.9

216.4

0.00

215

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2652

14264

1.74

142.17

1.8

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1916

9347

1.91

141.31

2.2

2.3

g/l

3.8

0.06

1320

6614

(3000494) Fungus identified in Specimen by Culture

4275

25994

1.56

141.29

1.6

1.4

—

(3021589) Normoblasts [#/volume] in Blood

13097

98045

1.36

140.68

11.8

10.0

e9/l

0.0

2.08

10668

80314

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1917

9371

1.90

140.49

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1918

9383

1.90

140.23

2.2

2.3

g/l

7.4

0.02

1367

6919

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

25693

215300

1.54

139.41

5.2

4.6

mmol/l

1.4

1.5

35.98

23656

195748

(3019060) Gas panel - Arterial blood

2934

16315

1.69

139.21

4.7

4.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

25865

217213

1.54

137.08

5.2

4.7

mmol/l

4.5

4.6

78.03

24050

198721

(4010399)

2948

16538

1.67

135.06

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2855

15893

1.69

134.66

2.7

2.8

g/l

10.6

0.40

2637

14483

(3028026) IgM [Mass/volume] in Serum or Plasma

2345

12389

1.77

133.44

1.9

g/l

1.4

1.3

0.88

2143

11166

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2429

13014

1.74

131.54

9.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3317

19358

1.61

129.64

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1787

8763

1.89

129.41

2.2

2.3

g/l

10.2

10.3

0.19

1467

7238

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1474

6794

2.01

127.97

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1778

8790

1.88

125.46

2.3

2.4

g/l

3.1

0.69

1346

6751

(3004119) Hemoglobin [Mass/volume] in Venous blood

2607

14461

1.69

124.09

4.2

3.3

g/l

124.8

128.6

13.36

2548

14131

(3002256) Pathology report gross observation

4684

29905

1.49

121.46

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1631

7935

1.90

120.79

2.4

2.5

g/l

0.9

1.0

0.57

1383

6705

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2088

11095

1.75

115.84

3.4

2.7

1.2

0.60

2081

11036

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3217

19113

1.58

115.77

2.3

nmol/l

364.7

376.5

2.71

2953

17526

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1230

5524

2.05

114.51

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1225

5503

2.05

113.96

1.3

1.2

titre

966.9

989.7

0.04

174

(3003338) MCHC [Mass/volume]

21768

178762

1.36

113.86

30.7

19.9

g/l

330.8

332.0

71.74

21616

177292

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4623

29798

1.47

113.46

10.1

7.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1500

7246

1.91

113.35

2.3

g/l

37.3

37.4

0.17

1268

6139

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1446

6900

1.94

113.35

2.3

2.4

g/l

0.0

0.13

1299

6273

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2044

10861

1.75

113.32

3.4

2.7

0.7

0.32

1971

10420

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2447

13674

1.67

112.76

1.6

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1902

9930

1.78

112.03

1.5

u/ml

13.5

16.2

0.38

256

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11289

84554

1.33

111.82

5.6

5.1

ug/l

3.2

3.6

0.59

10157

75399

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3479

21258

1.54

110.19

3.2

2.9

ng/l

241.3

218.9

1.74

3173

19502

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3457

21118

1.54

109.58

1.7

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1358

6416

1.95

109.54

2.3

2.4

g/l

0.0

0.64

1212

5814

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

763

2873

2.43

108.99

2.8

2.4

u/ml

174.0

1116.4

1.62

751

2811

(3007566) Smooth muscle Ab [Titer] in Serum

1217

5543

2.02

108.94

1.3

1.2

titre

104.4

138.3

0.88

483

(3000492) Spirometry study

3160

18973

1.56

108.15

1.6

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1337

6317

1.95

107.81

2.4

g/l

0.0

0.00

1211

5792

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2643

15356

1.61

103.87

7.3

7.1

mmol/l

24.6

24.7

0.64

2493

14311

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1306

6225

1.93

102.54

1.5

1.4

iu/ml

13.6

15.6

0.19

151

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1735

9102

1.76

100.20

4.6

3.8

mmol/l

24.7

24.9

3.03

1594

8341

(46235355) HIV 1 and 2 tests - Meaningful Use set

3823

24312

1.48

99.18

1.8

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5312

35924

1.41

98.85

1.3

iu/ml

29.6

40.8

6.14

1619

11300

(3022313) Gas panel - Capillary blood

1956

10670

1.70

98.19

4.4

3.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2580

15107

1.59

97.86

4.3

3.5

kpa

5.1

5.2

0.41

2391

13866

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2475

14378

1.60

97.00

4.2

3.5

mmol/l

1.5

1.9

5.20

1852

10734

(3009343) pH of Capillary blood

2547

14913

1.59

96.56

4.3

3.5

7.4

3.31

249

2058

(3002385) Erythrocyte distribution width [Ratio]

21536

178140

1.32

95.45

28.2

18.5

14.0

13.8

91.72

21239

174141

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1550

8007

1.79

94.22

2.8

3.4

mg/l

45.3

44.5

0.04

1330

6420

(3037121) Protein [Mass/volume] in Urine

1523

7844

1.79

93.50

3.2

3.1

g/l

0.3

0.18

691

3316

(3034860) Kappa light chains.free [Mass/volume] in Serum

1550

8025

1.78

93.49

2.8

3.4

mg/l

92.0

66.3

0.37

1331

6428

(4035726)

3345

20959

1.50

92.95

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1510

7785

1.79

92.36

2.8

3.4

ratio

3.0

4.9

0.63

635

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1598

8416

1.75

90.83

2.4

2.3

ug/l

445.5

582.7

1.04

1505

7942

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4984

33771

1.40

90.74

1.3

u/ml

13.7

13.9

0.03

1673

12505

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1049

4852

1.99

89.74

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1946

10865

1.66

89.18

5.2

3.9

48.2

47.6

0.49

1937

10742

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3004

18596

1.51

88.21

2.9

2.8

ml/min/173m2

60.7

62.8

2.11

1322

7482

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1476

7682

1.77

87.34

1.6

titre

211.1

262.0

0.33

372

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1484

7822

1.75

83.98

1.1

u/ml

3.5

6.7

0.38

120

(3027273) Bicarbonate [Moles/volume] in Venous blood

2056

11812

1.61

83.89

4.5

3.4

mmol/l

25.1

25.3

1.76

2013

11475

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3378

21621

1.46

83.69

1.8

1.7

1.6

1.5

9.35

2832

18549

(3020891) Body temperature

1744

9639

1.67

82.94

5.4

4.8

—

(3052851) Hemolysis interference index of Serum or Plasma

1363

7035

1.78

82.90

4.0

3.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1570

8490

1.71

80.98

2.7

—

(3019225) pH of Specimen

3686

24160

1.43

80.14

5.1

4.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10913

83947

1.27

79.50

5.1

4.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

1572

8548

1.70

79.41

4.3

4.1

mmol/l

1.4

0.56

1544

8390

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

303

834

3.30

77.66

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8946

67290

1.28

77.60

4.8

4.4

22.0

0.02

4650

34171

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1037

5029

1.89

77.03

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1037

5030

1.89

76.98

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2341

14206

1.53

74.89

7.8

6.7

mmol/l

24.8

0.06

2320

14065

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1008

4899

1.89

74.36

1.1

u/ml

6.2

8.0

0.39

490

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1021

4998

1.87

73.65

1.4

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1369

7357

1.71

72.09

4.4

mmol/l

3.9

1.42

1310

6891

(3024980) IgG subclass 4 [Mass/volume] in Serum

736

3255

2.07

71.20

1.7

1.5

g/l

0.7

0.8

2.31

573

2420

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6911

50771

1.30

70.61

1.8

1.7

pmol/l

32003199.1

31658995.8

0.02

5787

41120

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1185

6154

1.77

70.42

2.6

2.3

g/l

3.7

3.6

0.79

1137

5858

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1023

5111

1.83

69.15

3.2

3.3

u/ml

185.4

989.2

4.71

917

4651

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1738

10092

1.59

67.39

2.1

2.0

ug/l

2.0

2.2

0.29

1538

8850

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1164

6104

1.75

66.84

1.5

1.6

iu/ml

16.2

6.8

0.35

282

1376

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

432

1583

2.48

65.49

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

977

4904

1.82

65.02

3.7

2.4

umol/l

34.8

33.6

0.77

825

4092

(3007930) Methemoglobin/Hemoglobin.total in Blood

1714

10012

1.58

64.73

5.4

5.1

0.9

0.12

1632

9383

(3025468) Yersinia sp identified in Specimen by Organism specific culture

652

2856

2.08

64.72

1.5

1.4

—

(3024928) Oxygen saturation in Venous blood

964

4837

1.82

64.23

3.5

3.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

651

2861

2.08

64.06

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

650

2856

2.08

64.00

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1143

6049

1.73

63.52

2.7

3.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1730

10193

1.56

62.88

5.3

5.0

1.7

1.6

1.46

1647

9559

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

652

2889

2.06

62.77

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

662

2968

2.04

61.72

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3964

27373

1.35

61.66

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

650

2901

2.04

61.36

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

1029

5342

1.76

61.15

1.5

1.7

—

(3049717) Cytology report of Urine Cyto stain

1698

10045

1.56

60.57

2.9

2.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

606

2660

2.08

59.84

3.5

3.3

nmol/l

8.1

8.6

0.08

591

2584

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1153

6229

1.70

59.41

2.3

2.1

90.5

89.7

0.59

1097

5798

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1075

5707

1.73

59.04

2.5

2.4

201.0

198.8

0.33

1017

5380

(3036489) Thrombin time

1381

7830

1.62

58.98

2.1

1.9

22.3

21.7

1.50

1247

6910

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6474

48120

1.27

58.34

3.3

3.1

ug/l

0.8

0.90

4783

33076

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

607

2714

2.04

57.04

1.1

g/l

1.6

1.5

0.68

544

2442

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4165

29292

1.33

56.84

5.0

4.7

32.8

32.6

0.60

2964

19376

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2029

12633

1.48

56.77

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

894

4579

1.79

55.62

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1125

6148

1.68

55.49

1.6

g/l

0.2

0.25

1065

5798

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

418

1634

2.33

55.00

1.2

titre

127.1

158.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

418

1638

2.32

54.69

1.2

titre

210.2

165.1

0.44

298

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1150

6347

1.66

54.61

1.6

g/l

1.2

0.23

1092

6012

(3038177) Helicobacter pylori Ab [Presence] in Serum

637

2962

1.96

53.62

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1528

9153

1.53

51.34

1.9

u/l

39.3

39.0

0.22

1318

7941

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2196

14165

1.43

50.84

2.5

2.4

au/ml

25.8

28.7

0.32

641

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2019

12838

1.45

50.50

1.3

au/ml

46.2

52.8

0.53

549

(3005322) IgE [Units/volume] in Serum or Plasma

1878

11787

1.47

50.27

1.3

u/ml

208.4

244.4

0.63

1722

10885

(3044927) Protein electrophoresis panel - Urine

546

2493

1.99

48.45

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

330

1232

2.43

48.19

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

332

1243

2.43

48.18

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

2285

15012

1.40

47.57

3.0

e9/l

4.2

4.1

0.75

1633

11134

(21494890) Protein electrophoresis panel - 24 hour Urine

560

2598

1.96

47.49

1.7

2.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

830

4383

1.73

46.44

6.5

5.4

iu/ml

862.9

1330.1

0.44

150

672

(40760892) CBC W Ordered Manual Differential panel - Blood

6165

46612

1.24

46.16

5.2

4.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

935

5120

1.67

45.73

3.5

3.1

nmol/l

0.8

1.66

736

3960

(3017817) Protein [Mass] in Urine collected for unspecified duration

472

2111

2.03

44.40

2.1

2.4

—

0.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

721

3706

1.77

44.34

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

7756

60295

1.22

44.10

5.4

4.2

estimate

0.0

0.33

2017

20009

(3024891) Influenza virus A+B Ag [Presence] in Specimen

909

5014

1.66

43.23

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

676

3455

1.78

42.39

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1947

12688

1.41

42.31

3.1

2.8

e6/l

0.3

0.41

1899

12392

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

505

2360

1.95

41.97

3.8

3.6

—

(40768443) Skin Pathology biopsy report

1626

10310

1.45

41.08

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

637

3229

1.80

41.07

1.4

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1932

12654

1.40

40.74

3.0

3.3

pmol/l

4.3

4.4

1.58

1676

11157

(3003694) ABO and Rh group [Type] in Blood

7243

56345

1.21

40.14

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

919

5199

1.61

39.51

4.5

3.3

mmol/l

7.7

7.6

0.18

902

5105

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

232

808

2.60

39.28

1.2

—

(4062490)

449

2076

1.97

38.53

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1095

6495

1.54

38.38

5.2

4.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

449

2080

1.96

38.32

1.4

g/l

0.4

0.03

335

1427

(3028192) IgG subclass 2 [Mass/volume] in Serum

449

2081

1.96

38.27

1.4

g/l

2.8

3.0

1.51

333

1424

(3008037) Lactate [Moles/volume] in Venous blood

954

5490

1.59

38.20

4.4

3.2

mmol/l

1.6

0.59

938

5378

(3027135) IgG subclass 1 [Mass/volume] in Serum

449

2083

1.96

38.16

1.4

g/l

6.7

6.9

0.49

333

1426

(3045414) Leukocytes [Presence] in Urine

1574

10086

1.43

37.50

2.0

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2312

15819

1.35

37.05

2.4

2.1

nmol/l

11.8

12.4

2.45

1973

13857

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1309

8122

1.47

36.96

1.2

u/ml

0.4

0.9

3.45

127

756

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

826

4632

1.63

36.82

1.2

titre

166.7

135.2

0.14

101

(3000330) Specific gravity of Urine by Test strip

1827

12072

1.39

36.48

4.6

3.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

470

2249

1.90

36.46

3.3

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

624

3283

1.73

35.44

7.2

6.0

mg/l

12.2

11.9

0.83

564

3006

(3000475) Leukocytes [#/volume] in Synovial fluid

991

5859

1.54

35.25

1.7

1.6

e6/l

16156.9

13830.3

0.76

716

4254

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1555

10068

1.42

34.93

2.1

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

652

3490

1.70

34.79

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

618

3263

1.72

34.66

1.3

1.2

u/ml

309.3

280.2

1.33

410

2051

(3026250) Tacrolimus [Mass/volume] in Blood

226

829

2.47

34.44

36.4

33.2

ug/l

7.0

7.3

0.88

203

737

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

928

5466

1.55

33.58

1.6

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

816

4669

1.59

33.49

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1436

9258

1.42

33.02

1.9

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

696

3850

1.65

32.79

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

461

2278

1.84

32.40

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

957

5735

1.52

32.00

3.4

2.8

mg/l

1.8

1.6

7.88

887

5165

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

475

2383

1.81

31.80

1.7

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

583

3104

1.71

31.76

3.0

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

492

2497

1.79

31.70

4.0

3.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

600

3222

1.69

31.67

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

452

2239

1.83

31.54

1.1

u/ml

4.3

3.7

0.19

139

929

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

687

3826

1.63

31.52

1.6

1.4

u/ml

26.8

18.8

0.90

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

346

1569

2.00

31.48

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

341

1539

2.01

31.44

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1062

6532

1.48

31.32

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

229

885

2.34

31.17

3.0

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

582

3121

1.70

30.89

1.5

e6/l

1798.9

3003.5

1.88

407

2303

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

448

2230

1.82

30.78

1.8

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

581

3118

1.69

30.75

1.4

1.3

nmol/l

2.1

1.6

0.13

551

3000

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

628

3442

1.66

30.69

1.6

1.4

u/ml

115.9

117.4

0.12

139

802

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

984

5997

1.50

30.37

2.5

2.3

ug/min

122.1

112.2

0.30

575

3456

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

949

5741

1.51

30.36

1.3

u/ml

22.5

41.5

2.01

345

(3045424) Erythrocytes [Presence] in Urine

674

3774

1.63

30.28

1.5

—

(3051651) Icteric interference index of Serum or Plasma

308

1360

2.05

30.17

4.2

3.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

635

3506

1.65

30.17

1.6

1.5

g/l

30.9

32.9

3.37

549

3170

(40768441) Liver Pathology biopsy report

338

1544

1.99

30.14

1.6

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

490

2532

1.76

29.72

1.2

u/l

56.3

62.7

0.99

322

1685

(3003181) Sodium [Moles/volume] in Urine

744

4292

1.58

29.53

1.4

1.3

mmol/l

60.3

62.2

0.69

591

3420

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

577

3129

1.68

29.39

1.4

1.3

nmol/l

0.2

0.3

0.83

247

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

270

1149

2.13

29.17

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

270

1149

2.13

29.17

1.5

1.4

—

(3039000) Anion gap in Blood

900

5443

1.51

28.84

6.8

6.9

mmol/l

11.2

0.05

826

4902

(3018572) Chloride [Moles/volume] in Blood

900

5444

1.51

28.81

6.8

6.9

mmol/l

105.2

105.0

0.43

826

4903

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

264

1124

2.13

28.50

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

264

1125

2.13

28.44

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

701

4024

1.59

28.43

1.5

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

759

4448

1.55

28.14

1.2

u/ml

5.0

5.4

0.04

360

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

511

2720

1.71

27.92

1.3

1.2

u/ml

3.8

4.0

0.14

240

1208

(21494434) Karyotype in Bone marrow

412

2068

1.81

27.60

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

304

1382

1.99

27.54

1.2

u/l

31.8

24.4

1.05

256

1179

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

877

5332

1.50

27.41

1.3

u/ml

8.6

6.9

0.35

125

890

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

310

1422

1.98

27.38

1.2

u/l

101.2

90.6

0.84

266

1243

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

867

5262

1.50

27.33

1.3

u/ml

5.3

6.4

0.20

575

(3042733) HLA Ab [Presence] in Serum

175

638

2.48

27.14

5.7

4.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

562

3092

1.65

27.12

2.7

2.0

mg/l

25.5

27.6

0.36

132

839

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

529

2865

1.68

27.11

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

7092

71922

0.86

27.11

3.4

3.1

—

(44806118)

461

2413

1.74

26.78

1.6

1.5

—

(44790049)

461

2414

1.73

26.74

1.6

1.5

—

(44790048)

461

2414

1.73

26.74

1.6

1.5

—

(44790047)

461

2414

1.73

26.74

1.6

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

599

3362

1.62

26.70

3.0

2.5

u/ml

1178.4

5367.6

0.84

212

(3028308) Erythrocytes [#/volume] in Pleural fluid

523

2843

1.67

26.45

1.5

e6/l

63785.2

57400.1

0.16

306

1729

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1015

6415

1.44

26.03

1.6

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

282

1275

2.01

25.97

2.3

2.1

umol/l

16.9

27.0

1.14

114

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7496

60301

1.16

25.76

1.7

mmol/l

1.4

5.29

6472

49637

(3047181) Lactate [Moles/volume] in Blood

1170

7603

1.40

25.70

6.3

6.0

mmol/l

1.2

1.3

2.15

1040

6720

(3009214) Lutropin [Units/volume] in Serum or Plasma

680

3972

1.56

25.61

1.4

1.3

u/l

11.7

11.5

0.14

553

3200

(3010375) cycloSPORINE [Mass/volume] in Blood

224

935

2.17

25.49

31.3

28.9

ug/l

113.5

113.0

0.04

184

791

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2949

21816

1.24

25.40

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

516

2831

1.66

25.20

1.3

1.2

u/ml

3.3

4.0

0.42

177

992

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

499

2730

1.66

24.65

1.4

1.3

nmol/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

638

3708

1.56

24.58

1.9

pmol/l

185.1

196.1

2.05

583

3484

(3016650) Hepatitis A virus Ab [Presence] in Serum

557

3140

1.61

24.43

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

932

5870

1.45

24.37

2.1

1.9

mg/l

12.5

11.3

4.59

860

5419

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

744

4491

1.51

24.11

1.2

u/ml

11.9

12.9

—

(3006270) Folate [Moles/volume] in Blood

375

1917

1.77

23.71

1.3

1.2

nmol/l

319.1

347.6

1.85

292

1560

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

828

5142

1.47

23.32

1.8

1.7

nmol/l

42.7

43.5

0.47

796

4966

(3023487) Leukocytes [#/volume] in Peritoneal fluid

202

842

2.17

23.12

2.5

1.8

e6/l

3493.9

3586.2

0.01

151

569

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

865

5427

1.45

23.10

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1094

7164

1.39

22.98

1.8

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

294

1419

1.88

22.43

1.7

—

(3036603) Volume of Urine

312

1538

1.84

22.28

1.7

1.6

1878.2

1970.1

0.40

388

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

642

3827

1.52

22.11

1.3

u/l

36.9

37.8

0.06

559

3308

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

678

4089

1.51

22.10

1.2

u/ml

35.1

46.5

1.06

422

(3012441) Differential panel - Pleural fluid

483

2700

1.62

21.98

1.5

—

(3017704) Immunofixation for Urine

284

1369

1.88

21.77

1.4

1.6

—

(3045788) Cell count panel - Pleural fluid

437

2390

1.66

21.68

1.5

—

(3005570) Glucose [Moles/volume] in Urine

425

2309

1.67

21.63

1.9

—

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

389

2065

1.71

21.59

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

389

2065

1.71

21.59

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

389

2065

1.71

21.59

1.7

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

282

1361

1.88

21.54

1.4

umol/l

13.7

13.3

0.32

265

1286

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

884

5648

1.42

21.42

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

395

2122

1.69

21.00

1.5

iu/ml

20.1

28.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

301

1497

1.82

20.92

1.0

1.1

mg/l

293.7

289.6

0.37

259

1337

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

681

4165

1.49

20.76

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

176

727

2.19

20.67

2.0

1.9

—

(3044941) Cell count panel - Synovial fluid

619

3726

1.51

20.40

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

479

2728

1.59

20.23

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

129

475

2.46

19.75

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

227

1050

1.96

19.74

2.5

1.9

91.4

98.4

1.92

216

987

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

321

1659

1.75

19.65

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1459

10218

1.30

19.62

1.9

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

458

2601

1.60

19.59

1.2

u/ml

55.5

56.8

0.03

186

(3021788) Differential panel - Synovial fluid

711

4437

1.46

19.59

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

274

1353

1.83

19.53

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

422

2356

1.62

19.36

1.4

1.3

mmol/l

6.8

6.3

2.90

386

2183

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

426

2386

1.62

19.30

1.4

1.3

u/l

509.0

467.9

0.10

401

2260

(3026692) Albumin [Mass/volume] in Peritoneal fluid

148

589

2.27

19.05

1.7

1.3

g/l

13.1

13.5

0.23

118

449

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

705

4422

1.45

18.92

1.8

1.6

nmol/l

0.9

0.8

1.32

585

3657

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1467

1.79

18.84

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1475

1.78

18.78

1.2

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

231

1096

1.91

18.67

2.2

2.4

u/ml

1068.3

1273.8

0.62

222

1082

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

174

746

2.11

18.66

2.3

1.7

e6/l

5952.0

11830.7

0.81

108

401

(40759836) Histone Ab [Presence] in Serum by Immunoblot

288

1465

1.78

18.65

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1474

1.78

18.55

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

288

1468

1.78

18.52

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1475

1.78

18.50

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

230

1094

1.90

18.46

1.2

1.1

iu/ml

2.9

4.6

1.42

(3011985) Renin [Units/volume] in Plasma

507

2989

1.54

18.46

1.3

1.4

mu/l

73.8

57.1

0.82

447

2640

(4094501)

949

6306

1.37

18.29

1.1

—

(3023419) Bacteria identified in Sputum by Culture

521

3099

1.53

18.21

2.6

2.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

340

1825

1.69

18.21

1.4

u/l

13.5

12.9

0.95

332

1750

(21494755) Public health laboratory ask at order entry panel

1191

13952

0.76

18.20

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

237

1146

1.87

18.10

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

253

1249

1.83

18.09

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

539

3234

1.51

18.09

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1497

10636

1.28

18.03

3.1

3.8

u/ml

45.2

65.6

2.57

1433

10251

(3006462) Nitrate [Presence] in Urine

225

1073

1.90

17.93

4.5

3.2

—

(1002224) Polysomnography panel

1069

7258

1.34

17.92

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

253

1254

1.83

17.87

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

526

3150

1.52

17.82

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

456

2653

1.56

17.64

1.3

—

(3024471) HLA-A [Type]

156

658

2.15

17.48

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1306

9156

1.30

17.44

1.8

1.6

—

(3024932) HLA-DR beta [Type]

153

643

2.15

17.31

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

307

2.71

17.25

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

146

603

2.19

17.25

1.7

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

319

1715

1.69

17.02

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

402

2291

1.59

17.02

1.4

e6/l

200749.0

116296.7

1.17

281

1563

(3015235) Bicarbonate [Moles/volume] in Capillary blood

938

6297

1.36

16.96

3.3

3.0

mmol/l

24.4

24.9

2.61

833

5513

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

753

4880

1.40

16.91

1.2

1.1

—

(4211845)

237

1172

1.83

16.90

4.4

3.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

787

5140

1.39

16.88

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

466

2752

1.54

16.88

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

344

1891

1.65

16.86

1.3

u/l

11.8

13.6

0.79

322

1742

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

535

3255

1.49

16.83

1.6

1.9

ug/l

24.5

24.8

0.03

523

3186

(3018851) Theophylline [Moles/volume] in Serum or Plasma

208

3.08

16.82

1.6

umol/l

54.1

43.8

1.33

208

(4268621)

334

1828

1.66

16.66

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

200

942

1.92

16.59

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

357

1990

1.63

16.57

1.2

1.1

95.3

95.5

0.04

334

1846

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

599

3749

1.45

16.33

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

283

1493

1.72

16.21

1.6

1.5

u/l

4.7

6.5

1.36

144

701

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

468

2792

1.52

16.20

1.3

pmol/l

280.1

278.7

0.03

381

2126

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

323

1767

1.66

16.16

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

219

1073

1.85

16.11

2.5

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

653

4166

1.42

16.06

1.7

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

258

1332

1.75

15.96

2.3

2.5

e6/l

495.7

534.7

0.34

221

1132

(4306422)

458

2729

1.52

15.95

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

439

2597

1.53

15.81

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

248

1270

1.77

15.79

2.3

2.5

e9/l

0.2

0.13

221

1125

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

445

2647

1.52

15.63

1.2

1.1

120.7

117.5

1.21

411

2359

(3017181) Myelocytes/100 leukocytes in Blood

2601

19917

1.20

15.55

4.2

4.0

1.0

0.9

0.54

840

5868

(3019420) Tryptase [Mass/volume] in Serum or Plasma

201

970

1.88

15.53

1.6

1.5

ug/l

9.5

8.9

0.14

189

880

(40768446) Kidney Pathology biopsy report

172

791

1.97

15.34

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

405

2375

1.55

15.20

2.0

u/l

1187.5

3320.1

2.57

113

848

(3003129) Base excess in Capillary blood by calculation

141

606

2.10

15.13

2.1

1.7

mmol/l

0.4

0.6

0.28

130

575

(3032057) Clostridioides difficile [Presence] in Stool

125

514

2.20

15.00

1.9

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

576

3650

1.43

14.74

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

537

3360

1.45

14.71

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

123

510

2.18

14.48

2.8

2.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

250

1321

1.71

14.31

3.1

1.8

nmol/l

17.7

16.2

2.10

240

1225

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

231

1195

1.75

14.26

2.2

ug/min

103.3

107.9

0.04

267

(4146454)

459

2805

1.48

14.21

2.9

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

363

2112

1.56

14.15

1.8

2.0

g/24h

0.5

1.0

1.29

(3008898) HLA-B27 [Presence]

794

5355

1.35

14.00

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

364

2126

1.55

13.96

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

155

715

1.96

13.76

1.8

1.5

umol/l

2.0

0.01

148

664

(3002331) Protein [Mass/volume] in Peritoneal fluid

125

535

2.11

13.62

1.4

g/l

26.0

39.7

0.66

420

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

696

4625

1.37

13.52

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

160

751

1.93

13.52

1.5

1.7

u/ml

20350.8

31956.1

0.22

114

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

1070

1.77

13.41

1.2

—

(3045142) Bone marrow Pathology biopsy report

436

2673

1.48

13.32

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

377

2244

1.52

13.29

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

223

1167

1.73

13.26

1.5

1.8

—

(3018133) Calcium [Moles/volume] in Urine

255

2.62

13.15

1.3

1.6

mmol/l

2.4

2.7

0.63

219

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

342

2001

1.55

13.05

1.4

1.3

nmol/l

1.5

1.4

1.01

313

1804

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

1961

1.55

12.97

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1625

12120

1.22

12.78

1.2

iu/ml

112.5

139.8

2.40

572

4430

(3021387) Prolactin [Units/volume] in Serum or Plasma

616

4053

1.38

12.75

1.9

1.8

mu/l

280.4

307.9

1.11

569

3712

(3020491) Glucose [Moles/volume] in Blood

281

1580

1.61

12.73

1.8

1.9

mmol/l

7.4

7.2

0.56

184

1103

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

122

534

2.07

12.57

1.2

pmol/l

333.5

282.5

0.38

382

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

565

3674

1.40

12.56

1.9

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

221

1173

1.71

12.52

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

228

1221

1.69

12.50

1.2

u/l

359.0

321.7

0.10

204

1142

(3044007) Cell count panel - Peritoneal fluid

145

677

1.94

12.48

2.4

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

105

438

2.17

12.26

1.2

umol/l

17.1

16.7

0.45

388

(3035320) C reactive protein [Mass/volume] in Body fluid

285

1625

1.59

12.20

2.4

2.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

265

1489

1.61

12.07

2.3

2.5

e6/l

611.6

702.0

0.50

119

615

(3023383) Lactate [Moles/volume] in Pleural fluid

161

788

1.85

12.03

1.4

1.3

mmol/l

3.5

0.08

149

722

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

151

724

1.89

12.03

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

124

557

2.01

11.94

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

112

485

2.09

11.90

3.0

mg/l

6.6

7.6

0.89

100

383

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

179

910

1.78

11.83

2.8

2.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

162

799

1.83

11.82

1.8

1.5

umol/l

27.6

29.8

1.68

155

766

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

132

610

1.96

11.74

1.5

1.4

19.2

22.6

0.85

107

515

(44813793)

237

1309

1.64

11.59

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

338

2030

1.51

11.50

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

123

560

1.99

11.43

4.7

1.9

ug/l

1.3

1.1

0.28

118

532

(3004775) Volume in Urine collected for unspecified duration

339

2040

1.51

11.43

2.5

2.2

716.7

676.5

0.89

227

1353

(3022493) Free Hemoglobin [Mass/volume] in Plasma

186

967

1.74

11.40

7.8

4.0

mg/l

953.1

1612.6

0.27

143

677

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

226

1243

1.65

11.25

1.6

1.4

u/l

6.2

6.0

0.10

183

1045

(3020717) Zinc [Moles/volume] in Serum or Plasma

175

899

1.76

11.19

1.6

1.4

umol/l

22.5

25.3

0.61

170

842

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

304

1796

1.53

11.18

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

681

4648

1.33

11.17

2.1

1.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.96

11.12

1.1

1.0

u/ml

35.8

33.6

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.96

11.12

1.1

1.0

u/ml

26.4

25.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

816

5716

1.30

11.09

2.5

2.2

g/l

125.5

129.1

3.29

546

4154

(3008757) Leukocyte morphology finding [Identifier] in Blood

429

2720

1.43

11.08

3.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

2.42

11.03

4.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

240

1347

1.61

11.03

1.9

1.8

—

(3035880) pH of Pleural fluid

251

1429

1.59

10.88

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

2418

18951

1.16

10.86

4.3

4.1

0.1

0.27

755

5461

(3016244) Insulin [Units/volume] in Serum or Plasma

170

874

1.76

10.86

2.5

3.1

mu/l

26.8

24.6

0.28

162

812

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

634

1.90

10.84

1.2

g/l

0.3

0.24

104

513

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

367

2270

1.46

10.83

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

311

1864

1.51

10.72

1.5

1.6

u/ml

21.9

25.6

0.96

388

(3025159) Blasts/100 leukocytes in Blood

2272

17740

1.17

10.71

4.3

4.1

0.2

0.3

0.21

655

4605

(3004809) Band form neutrophils/100 leukocytes in Blood

603

4069

1.34

10.71

3.3

3.4

1.7

1.5

0.73

491

3113

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

542

3599

1.37

10.68

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

269

1567

1.55

10.58

1.2

1.1

mmol/l

32.8

34.7

0.63

231

1320

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

708

4900

1.31

10.55

1.7

iu/l

4.9

12.7

0.85

191

1683

(3028433) Virus identified in Specimen by Culture

148

737

1.82

10.53

1.2

—

(3022621) pH of Urine by Test strip

1969

15220

1.18

10.52

3.6

3.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

125

591

1.91

10.46

1.2

110.0

113.2

0.53

105

521

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

264

1536

1.56

10.44

1.3

titre

47.6

73.7

0.80

135

(43055442) Apixaban [Mass/volume] in Serum or Plasma

349

2.20

10.40

1.7

1.5

ug/l

101.8

113.7

0.52

290

(3017354) Segmented neutrophils/100 leukocytes in Blood

398

2527

1.43

10.24

3.3

3.4

59.1

0.02

290

1589

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

494

3258

1.37

10.19

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

315

1922

1.48

10.00

1.7

1.9

mg/l

3.8

4.1

0.73

297

1830

(3034274) Bile acid [Moles/volume] in Serum --fasting

205

1139

1.63

9.87

1.5

umol/l

7.8

11.7

1.79

150

812

(3002179) Metamyelocytes/100 leukocytes in Blood

2297

18084

1.16

9.72

4.0

3.9

0.7

0.6

0.39

607

4221

(3019832) Treponema pallidum Ab [Presence] in Serum

1132

8377

1.23

9.68

1.6

1.5

—

(4015189)

139

698

1.80

9.67

2.3

2.2

—

(3011412) CD3 cells [#/volume] in Blood

324

2004

1.46

9.62

2.3

e9/l

1.1

0.21

175

1235

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

482

3200

1.36

9.57

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

102

465

1.98

9.53

1.2

1.3

mu/l

88.6

62.0

0.56

334

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

266

1586

1.52

9.47

1.3

titre

181.4

482.0

1.81

137

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

100

457

1.98

9.29

2.6

2.3

au/ml

164.3

164.7

0.00

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

172

929

1.67

9.28

1.4

61.7

63.2

0.21

141

756

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

212

1207

1.59

9.27

2.7

2.8

38.5

37.7

0.16

405

(3051593) INR in Capillary blood by Coagulation assay

222

1280

1.57

9.20

9.0

10.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

321

2002

1.45

9.16

1.5

1.3

u/l

32.7

34.1

0.27

257

1623

(3041672) Baker's yeast Ab [Presence] in Serum

3.87

9.15

1.1

1.0

—

(1616796) Gas panel - Central venous blood

781

5583

1.27

9.12

4.3

3.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

555

3793

1.33

9.12

1.3

miu/ml

221.7

212.0

0.21

207

1522

(3006245) CD3-CD19+ cells/100 cells in Blood

130

652

1.80

9.11

2.0

10.2

10.4

0.07

117

590

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

136

2.86

9.10

2.4

2.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

276

1673

1.49

9.10

1.3

1.2

u/ml

2.3

9.1

2.03

108

(3014271) Vancomycin [Susceptibility]

238

1398

1.54

9.09

3.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

608

4213

1.31

9.05

3.7

3.2

—

(40762365) Oxygen content in Arterial blood by calculation

413

2.01

9.00

4.1

2.8

ml/dl

14.5

14.8

0.51

383

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

120

590

1.84

8.98

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

623

1.81

8.95

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6848

57681

1.09

8.89

4.2

3.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

180

997

1.63

8.84

2.0

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

841

9391

0.80

8.76

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

286

1761

1.47

8.74

1.2

u/ml

70.5

84.6

0.33

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

128

648

1.79

8.72

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3070

24826

1.13

8.72

3.9

3.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

483

3261

1.34

8.65

1.6

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

129

657

1.77

8.62

2.0

29.5

30.0

0.13

120

614

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

286

1767

1.46

8.60

1.2

u/ml

41.1

44.8

0.10

135

(3038026) Centromere Ab [Units/volume] in Serum

292

1812

1.46

8.59

1.2

u/ml

64.8

54.8

0.15

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

789

5700

1.26

8.46

1.3

—

(3023410) Appearance of Cerebral spinal fluid

317

2005

1.43

8.43

1.6

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

341

2191

1.41

8.31

3.5

2.9

mg/l

65.8

44.1

0.60

245

1575

(3029634) Reagin Ab [Titer] in Serum by VDRL

367

2389

1.39

8.29

2.3

2.1

titre

3.2

6.2

0.54

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

731

5253

1.26

8.22

1.3

mg/l

565.0

576.7

0.10

686

4995

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

654

4638

1.28

8.20

1.2

1.3

mmol/l

3.8

0.00

604

4367

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

244

1476

1.50

8.18

2.0

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

346

2240

1.40

8.09

1.1

iu/ml

2.0

1.9

0.03

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

463

3144

1.33

8.01

1.1

iu/ml

80.2

4001.2

0.58

631

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

175

988

1.60

8.00

2.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

175

989

1.60

7.97

2.0

1.9

—

(4212803)

217

2.33

7.95

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

350

2287

1.39

7.77

1.4

mosm/kgh2o

278.8

277.3

0.50

258

1765

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

646

1.73

7.72

2.6

3.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

157

872

1.63

7.69

1.5

1.6

nmol/l

3.8

7.1

0.60

130

738

(3036670) Protein [Mass/volume] in Synovial fluid

141

763

1.67

7.65

1.2

1.3

g/l

39.0

40.1

0.41

399

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1395

14660

0.85

7.63

1.9

1.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

321

2.05

7.63

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

291

2.11

7.63

1.2

1.3

nmol/l

110006.0

243941.4

0.42

239

(3016750) Collection duration of Urine

240

1474

1.47

7.51

2.5

2.1

min

492.2

500.2

0.71

185

1061

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

402

2705

1.35

7.44

1.1

au/ml

6.7

12.1

—

122

(3028626) Oxygen [Partial pressure] in Capillary blood

750

5472

1.24

7.43

3.2

2.9

kpa

7.9

8.0

0.67

705

5048

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

337

2.01

7.40

1.3

1.2

ng/l

1123.3

145.1

0.45

228

(3020191) Ethanol [Moles/volume] in Serum or Plasma

260

1631

1.44

7.30

1.4

promille

1.3

0.01

202

1241

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

134

725

1.67

7.30

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

396

1.92

7.24

2.3

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

442

3040

1.32

7.06

4.7

umol/l

350.5

359.1

0.63

379

2575

(3042631) Mycobacterium sp identified in Specimen

515

3616

1.29

7.06

2.8

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

261

1650

1.43

7.05

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

277

2.09

7.01

1.3

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

144

806

1.61

6.89

1.5

2.1

159.6

160.7

0.05

132

748

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

229

1421

1.46

6.85

1.4

1.3

u/ml

1.1

1.5

0.36

138

713

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

204

2.26

6.79

2.4

2.2

54.4

60.5

0.48

129

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

384

2609

1.33

6.71

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

206

1258

1.48

6.69

1.1

u/l

28.7

27.1

0.15

171

938

(3020393) Adenovirus Ag [Presence] in Stool

194

2.28

6.69

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

134

2.56

6.65

1.6

1.1

mg/l

52.3

43.0

1.18

(3044290) Cell count panel - Cerebral spinal fluid

594

4280

1.26

6.62

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

2654

1.33

6.61

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

205

1256

1.48

6.56

1.1

u/l

93.3

88.1

0.38

173

976

(3023511) Choriogonadotropin [Units/volume] in Urine

176

1045

1.52

6.55

1.3

—

(4024509)

346

2324

1.35

6.54

1.6

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

130

2.57

6.52

1.4

1.3

pmol/l

14.7

17.8

0.59

109

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

158

2.40

6.44

2.3

2.2

19.4

16.3

0.19

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

205

1262

1.47

6.42

1.1

nmol/l

1.6

7.2

2.97

242

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

124

682

1.64

6.40

1.2

—

(4281824)

361

2449

1.33

6.40

1.2

1.1

—

(44806420)

132

738

1.62

6.39

2.5

2.4

—

(3028717) Thiamine [Mass/volume] in Blood

204

2.21

6.38

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

442

1.80

6.29

1.9

2.0

e6/l

2070.8

1113.2

0.25

235

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

1232

1.47

6.25

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

446

1.78

6.12

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

356

1.88

6.08

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

442

3109

1.29

6.05

1.6

1.5

60.3

59.3

0.19

299

1957

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

216

1360

1.44

6.04

1.2

mg/l

50.3

45.4

0.48

194

1131

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

141

2.43

6.02

1.2

1.4

u/l

122.1

1377.2

1.32

126

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

110

597

1.66

6.01

7.7

5.8

64.6

70.9

1.55

484

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

258

2.03

5.97

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3265

27037

1.10

5.97

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

146

852

1.55

5.93

1.6

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

176

2.26

5.91

1.2

1.3

ml/s/173m2

1.2

1.0

0.41

110

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

376

2601

1.31

5.85

1.1

u/ml

1.0

1.2

0.26

147

971

(3048879) Bone marrow aspiration report

132

757

1.58

5.79

1.6

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

231

2.07

5.77

1.2

ug/l

72.1

113.0

1.62

144

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

260

1707

1.38

5.74

1.5

1.4

nmol/l

0.3

0.30

192

1226

(3010370) Gastrin [Moles/volume] in Serum or Plasma

331

1.88

5.74

1.6

1.7

pmol/l

54.2

57.8

0.10

275

(3027923) C peptide [Moles/volume] in Serum or Plasma

197

1237

1.44

5.63

1.4

1.3

nmol/l

1.2

0.33

148

955

(1175426) CD3 cells/100 lymphocytes in Blood

239

1554

1.39

5.61

2.0

70.8

71.9

0.56

225

1484

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

205

1298

1.43

5.60

1.1

mg/l

334.1

299.4

0.67

188

1129

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

621

4593

1.22

5.53

1.4

e6/l

25.5

30.9

0.26

475

3568

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

621

4597

1.22

5.49

1.5

1.4

e6/l

4700.9

1619.2

0.41

496

3774

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

234

1523

1.39

5.47

2.0

15.2

15.4

0.06

116

597

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

597

4403

1.23

5.47

1.4

pmol/l

153.1

170.7

0.44

583

4289

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.01

5.45

1.0

1.2

ug/g

166.7

185.3

0.14

(3029075) Extractable nuclear Ab panel - Serum

105

579

1.64

5.44

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

269

1793

1.36

5.43

4.5

5.0

u/ml

58.3

120.8

1.76

515

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

129

748

1.56

5.43

1.3

ug/l

350.6

238.8

0.24

404

(3006576) Bicarbonate [Moles/volume] in Blood

149

892

1.51

5.42

6.4

6.3

mmol/l

24.8

25.1

0.38

136

803

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

243

2.01

5.42

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

268

1.95

5.41

2.0

2.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

124

714

1.57

5.38

1.5

1.4

pmol/l

16.0

15.8

0.10

111

586

(3021901) Oxygen saturation in Capillary blood

635

4723

1.22

5.37

3.2

2.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

314

1.87

5.33

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

295

1.90

5.32

2.4

2.5

pmol/l

76.0

74.9

0.03

257

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

229

1493

1.39

5.32

1.8

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

179

1118

1.45

5.29

1.1

iu/ml

9.7

9.5

0.03

239

(3024263) Appearance of Synovial fluid

200

1281

1.41

5.16

1.6

—

(3025315) Body weight

193

2.11

5.15

5.7

4.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

110

624

1.59

5.11

1.2

1.3

umol/l

3.2

3.3

0.17

102

572

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

148

898

1.49

5.08

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

304

2086

1.32

5.08

1.8

titre

1341.5

3030.5

0.85

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

307

1.85

5.05

2.4

2.0

—

(3022689) Creatine [Moles/volume] in Urine

114

655

1.57

5.03

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

954

1.47

4.97

1.2

1.1

u/l

1.2

1.1

0.28

462

(3000919) Neutrophils/100 leukocytes in Pleural fluid

124

729

1.54

4.95

1.4

21.0

20.8

0.03

111

657

(3003888) Timothy IgE Ab [Units/volume] in Serum

331

2307

1.30

4.95

1.1

u/ml

2.9

3.6

0.61

157

1057

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

1179

1.42

4.93

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

539

1.63

4.92

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

323

2247

1.30

4.90

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

692

5240

1.20

4.89

2.5

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

370

1.76

4.87

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

199

1291

1.39

4.80

1.9

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

217

2.00

4.80

1.5

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

249

1.92

4.76

1.1

u/l

16.3

19.5

0.86

163

(21494815) CD4 cells/100 lymphocytes in Specimen

262

1779

1.33

4.74

2.0

2.1

39.4

39.1

0.04

222

(3008401) Mugwort IgE Ab [Units/volume] in Serum

318

2219

1.30

4.73

1.1

u/ml

0.7

1.1

0.90

125

857

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

206

1350

1.38

4.69

1.8

1.9

u/field

2.8

2.6

0.17

140

942

(3001893) Eosinophils/100 leukocytes in Pleural fluid

134

812

1.49

4.67

1.5

1.4

3.0

2.6

0.18

112

675

(3012494) Peanut IgE Ab [Units/volume] in Serum

375

1.73

4.67

1.1

1.0

u/ml

0.6

0.8

0.25

181

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

512

1.62

4.66

1.7

1.8

mg/l

9.8

9.0

0.74

412

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

259

1761

1.33

4.66

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

198

1291

1.39

4.66

1.9

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

198

1291

1.39

4.66

1.9

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

198

1291

1.39

4.66

1.9

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

246

1.91

4.59

1.9

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1151

1.41

4.57

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

362

2585

1.27

4.51

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

285

1976

1.30

4.48

1.6

1.7

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.75

4.37

1.4

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

170

2.07

4.34

1.1

1.2

nmol/l

0.3

0.2

0.23

114

(40765096) Chromosome analysis panel by Banding

114

680

1.51

4.32

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

234

1590

1.33

4.27

2.0

2.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

1466

1.34

4.26

2.1

2.0

—

(40761536) Microorganisms panel - Urine sediment

1949

19293

0.91

4.26

5.2

4.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

164

1053

1.41

4.26

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

312

1.77

4.25

2.6

2.7

u/field

0.5

0.11

312

(3001964) Herpes simplex virus Ag [Presence] in Specimen

106

625

1.53

4.24

1.6

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

119

2.28

4.20

1.2

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

340

1.73

4.19

1.3

19.0

25.5

1.10

258

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.86

4.17

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

301

1.77

4.15

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

183

1205

1.37

4.11

3.5

3.4

—

(3017569) Oxygen content in Arterial blood

178

1168

1.38

4.09

2.4

2.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

143

904

1.43

4.07

12.6

12.5

mmol/l

0.6

0.35

131

823

(3049242) von Willebrand panel - Platelet poor plasma

2.81

4.06

1.6

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

490

1.59

4.02

1.1

umol/24h

0.8

0.09

232

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

207

1.92

4.00

1.1

u/ml

0.6

0.5

0.08

135

(3002619) Bacteria identified in Specimen by Culture

463

1.60

3.98

1.2

1.3

—

(3026480) Teichoate Ab [Titer] in Serum

208

1.91

3.95

1.2

1.0

—

2.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.55

3.92

1.3

ug/l

141.6

122.8

0.13

(4027681)

153

987

1.40

3.91

1.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

158

1025

1.39

3.90

1.2

1.1

—

(3034426) Prothrombin time (PT)

103

616

1.51

3.90

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

487

5262

0.83

3.88

4.3

3.5

mg/l

28.2

27.7

0.11

299

3378

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

112

2.26

3.87

4.5

3.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

502

1.57

3.87

1.2

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

404

1.63

3.85

3.0

5.3

u/l

51.0

52.7

0.05

158

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

286

2036

1.27

3.74

1.9

2.1

u/field

2.9

2.2

0.73

126

817

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

162

1065

1.37

3.72

1.2

1.3

—

(3004451) EKG impression Narrative

189

1276

1.34

3.67

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

137

878

1.41

3.66

1.6

2.2

ug/l

178.6

286.7

0.23

132

832

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

589

1.50

3.65

1.9

1.6

ug/l

9.3

9.2

0.08

589

(3025018) Bordetella pertussis Ab [Titer] in Serum

154

1008

1.38

3.64

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

576

1.51

3.61

1.3

nmol/l

104.6

138.2

1.86

411

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

562

1.51

3.60

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

463

1.56

3.55

1.8

2.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

344

1.65

3.54

3.0

2.4

mg/l

114.3

71.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

263

1.75

3.52

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

123

2.13

3.51

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

211

1.84

3.49

1.1

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

179

1.92

3.48

1.1

1.2

31.3

22.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.56

3.45

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

396

1.60

3.43

1.4

10.8

11.1

0.03

193

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

175

1183

1.34

3.40

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

328

1.65

3.37

1.5

1.2

u/l

577.0

172.6

0.33

232

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

240

1.77

3.37

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

199

1373

1.31

3.36

2.4

2.5

e9/l

0.2

0.4

1.82

192

1327

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

477

1.53

3.35

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

371

1.61

3.33

1.6

2.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

268

1.72

3.32

1.3

mmol/l

6.1

6.6

0.15

128

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

553

1.49

3.26

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

223

1.78

3.24

1.3

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

374

1.59

3.23

1.1

1.2

79.8

85.9

0.48

123

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

555

1.48

3.21

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.21

3.21

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

128

2.05

3.20

5.2

4.6

—

(3024869) Neuronal Ab [Presence] in Serum

454

1.53

3.19

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.76

3.15

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

131

858

1.38

3.14

2.3

umol/l

59.6

55.3

0.76

679

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

611

1.45

3.10

10.9

8.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

134

884

1.37

3.08

1.7

umol/l

90.7

116.3

0.85

457

(3020874) Milk IgE Ab [Units/volume] in Serum

121

785

1.39

3.08

1.1

1.0

u/ml

1.5

1.3

0.05

218

(3038071) Oxygen [Partial pressure] in Mixed venous blood

524

1.48

3.06

11.3

8.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

137

1.98

3.04

1.1

1.4

—

19393.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

182

1.84

3.02

1.1

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

325

1.61

3.00

6.4

4.9

ug/min

56.8

49.8

0.42

262

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

168

1154

1.32

2.98

1.1

—

(3011288) Drugs identified in Urine by Screen method

304

2244

1.22

2.97

2.3

3.0

—

(3009871) Measles virus Ab [Titer] in Serum

100

632

1.43

2.97

1.6

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

558

1.46

2.95

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

515

1.47

2.92

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

165

1.86

2.91

1.3

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

127

1.99

2.90

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

153

1.89

2.86

5.0

4.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

134

1.95

2.86

1.3

1.1

nmol/l

13.6

15.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

373

1.55

2.83

1.5

1.2

mmol/l

0.3

1.6

4.16

237

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

504

1.47

2.83

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

229

1652

1.25

2.79

1.2

1.3

mmol/l

2.1

2.2

1.63

209

1535

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

1128

1.31

2.77

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

149

1.88

2.74

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

553

1.44

2.72

1.1

83.8

86.6

0.27

272

(4198724)

479

1.47

2.72

1.7

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

495

1.46

2.69

1.5

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

536

1.43

2.60

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

374

1.52

2.60

1.2

72.6

74.7

0.14

117

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

338

1.55

2.60

1.1

—

(3010421) pH of Blood

814

6571

1.12

2.59

5.2

3.9

7.4

0.91

683

5620

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

130

881

1.33

2.58

1.1

ng/l

493.6

714.9

0.32

223

(3041918) Cholesterol [Moles/volume] in Pleural fluid

486

1.45

2.55

1.4

1.2

mmol/l

1.5

1.6

0.63

294

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

420

1.48

2.54

1.5

1.6

au/ml

81.9

90.0

—

(3017509) Phencyclidine [Presence] in Urine

115

1.96

2.53

1.6

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.53

2.52

3.1

3.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.53

2.52

1.4

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

133

909

1.32

2.50

1.1

u/ml

2.6

6.1

2.42

133

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

214

1554

1.24

2.50

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

184

1313

1.27

2.50

6.0

6.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

169

1194

1.28

2.49

2.4

1.9

—

(3019977) pH of Arterial blood

197

1421

1.25

2.45

3.0

2.5

7.4

0.42

513

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.80

2.42

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

705

5670

1.12

2.42

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

567

1.40

2.42

1.1

82.3

86.9

0.70

277

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

238

1.63

2.40

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

131

1.86

2.36

1.1

u/l

38.5

105.4

0.70

(3010838) Calcium [Moles/time] in 24 hour Urine

167

1188

1.27

2.35

1.6

mmol/24h

8.2

5.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.12

2.35

1.2

1.1

nmol/l

191.4

294.4

2.93

(3013166) Neutrophils/100 leukocytes in Synovial fluid

112

755

1.34

2.34

1.3

1.4

59.5

57.2

0.25

647

(1001926) Buprenorphine [Presence] in Urine by Screen method

344

2636

1.18

2.34

1.7

2.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

318

1.53

2.34

1.7

1.4

70.7

73.1

0.23

269

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1451

12121

1.08

2.33

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

113

764

1.34

2.32

1.0

u/ml

1.8

0.7

0.49

167

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

100

1.99

2.32

1.1

1.2

ng/l

5530.7

2761.1

0.24

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

132

1.85

2.31

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

269

1.58

2.31

1.7

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

122

835

1.32

2.31

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

285

2152

1.20

2.30

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.26

2.30

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

605

1.37

2.26

1.4

1.6

ug/l

0.4

0.00

387

(3027315) Oxygen [Partial pressure] in Blood

715

5785

1.12

2.24

5.4

4.0

kpa

8.3

8.5

1.72

695

5645

(3023323) Follitropin [Units/volume] in Serum or Plasma

685

5530

1.12

2.23

1.4

1.3

iu/l

31.1

34.7

1.98

579

4774

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

419

1.44

2.20

1.0

1.1

pmol/l

1.6

3.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

215

1590

1.22

2.17

1.2

mmol/l

12.3

11.9

0.34

119

470

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

398

1.45

2.16

1.4

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

1.73

2.16

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

306

2343

1.18

2.14

1.6

1.5

24.4

29.0

1.75

198

1442

(40765089) Chromosome analysis panel - Blood by G-banded

197

1.65

2.13

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.28

2.11

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

111

764

1.31

2.06

1.0

1.1

miu/ml

1589.2

1561.5

0.09

111

764

(3027874) Urate [Moles/volume] in Urine

2.03

1.2

1.0

mmol/l

1.6

1.8

0.39

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

119

829

1.30

2.03

2.8

3.0

umol/l

29.8

28.4

0.78

635

(3024316) Viscosity of Plasma

112

1.85

2.02

2.6

1.8

mpas

1.6

1.8

0.48

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.12

2.02

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

106

1.87

2.00

1.8

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

840

1.29

1.98

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.30

1.97

6.4

9.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

252

1.54

1.96

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

755

1.30

1.95

2.9

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

755

1.30

1.95

2.9

2.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.48

1.94

1.0

—

(3025577) Chromium [Mass/volume] in Blood

220

1655

1.20

1.91

2.0

ug/l

2.3

0.03

178

1378

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.02

1.90

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

478

1.38

1.90

1.8

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

704

5754

1.11

1.89

5.4

4.0

kpa

5.0

0.87

684

5615

(3001686) Cold agglutinin [Titer] in Serum or Plasma

418

1.40

1.88

1.5

1.4

titre

219.9

165.4

0.11

(3040151) Glucose [Moles/volume] in Capillary blood

366

2877

1.15

1.87

6.3

9.6

mmol/l

7.5

0.06

283

2381

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

573

1.34

1.85

1.1

108.5

105.9

0.20

521

(3012501) Base excess in Blood by calculation

703

5753

1.11

1.85

5.4

4.0

mmol/l

2.8

2.6

1.47

502

3978

(3021162) Amylase [Enzymatic activity/volume] in Specimen

405

1.40

1.83

2.6

2.7

u/l

782.1

1730.4

1.01

360

(3008402) Methanol [Moles/volume] in Serum or Plasma

213

1.57

1.83

1.2

mmol/l

—

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.30

1.83

1.0

umol/l

245.3

386.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

332

1.44

1.78

1.3

59.2

50.7

0.57

152

(3016879) Cocaine [Presence] in Urine

405

3219

1.14

1.78

1.7

2.0

—

(3030313) Adrenal Ab [Titer] in Serum

111

1.79

1.76

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.54

1.75

2.3

4.7

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.82

1.71

2.0

mg/l

1.7

2.1

0.75

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

133

1.70

1.69

1.0

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

147

1.66

1.68

1.2

1.6

umol/l

0.7

0.8

0.19

109

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

420

1.38

1.68

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

224

1716

1.18

1.64

1.0

ng/l

294.6

348.7

1.32

163

1187

(3037556) Urate [Mass/volume] in Serum or Plasma

104

737

1.27

1.62

1.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

666

1.29

1.61

2.0

2.1

u/l

48.0

39.6

0.16

605

(3014891) Appearance of Pleural fluid

370

1.39

1.61

1.8

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

224

1723

1.17

1.58

1.0

ng/l

746.2

727.0

0.23

160

1148

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

143

1.64

1.58

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

189

0.48

1.57

1.4

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

222

1707

1.17

1.57

2.0

ug/l

4.5

3.7

0.63

198

1498

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

208

1.52

1.55

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

224

1726

1.17

1.55

1.0

ng/l

42.0

43.4

0.15

161

1173

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

735

1.27

1.53

1.4

iu/ml

1522160.0

2172140.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.85

1.53

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

112

808

1.25

1.52

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

268

1.45

1.52

2.0

umol/l

15.8

17.7

0.73

268

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

166

1.58

1.51

1.1

u/l

9.6

10.8

0.14

166

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

124

1.67

1.51

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.46

1.48

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

111

1.71

1.48

1.0

1.4

u/field

0.9

1.2

1.19

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

218

1.49

1.48

1.2

1.1

iu/ml

13.5

18.8

0.36

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

455

3692

1.11

1.47

3.0

3.6

u/ml

35.3

40.2

0.21

444

3565

(3000764) Benzodiazepines [Presence] in Urine

426

3447

1.12

1.46

1.7

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

112

1.69

1.44

5.0

7.5

—

(3000285) Sodium [Moles/volume] in Blood

325

1.39

1.43

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

176

1.54

1.43

1.2

1.1

u/ml

0.6

3.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

192

1.50

1.38

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.01

1.37

1.2

1.0

umol/l

21.4

21.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

328

1.38

1.37

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

200

1.49

1.37

1.1

—

(3028300) Cannabinoids [Presence] in Urine

428

3480

1.11

1.36

1.7

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

114

1.66

1.36

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

427

3472

1.11

1.36

1.7

1.9

—

(3027944) Amphetamines [Presence] in Urine

418

3398

1.11

1.34

1.7

1.9

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.83

1.33

5.4

5.9

mg/l

0.8

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

123

913

1.22

1.33

15.6

15.9

nmol/l

1256.2

2510.8

0.63

117

871

(40768800) Prostate Pathology biopsy report

668

5560

1.09

1.31

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.41

1.30

1.4

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

123

1.61

1.29

1.3

1.2

g/l

0.1

0.84

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

109

1.66

1.29

1.7

1.5

mg/l

0.7

1.9

1.73

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

109

1.66

1.29

1.7

1.5

mg/l

5.3

3.3

0.53

(3050794) Legionella sp Ab [Presence] in Serum

203

1.47

1.29

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

256

2027

1.14

1.28

1.1

u/ml

1.3

0.01

459

(3027035) Albumin [Mass/time] in 24 hour Urine

218

1.45

1.28

1.6

1.3

mg/24h

901.7

223.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

145

1098

1.19

1.28

1.2

1.1

ratio

1.1

1.66

388

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

585

1.27

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

654

5447

1.09

1.27

3.0

2.5

15.6

16.2

4.18

380

2816

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

174

1.50

1.27

2.2

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.10

1.27

1.2

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

242

0.60

1.26

1.9

2.4

mmol/l

6.9

7.5

—

123

(3027974) Hepatitis B virus e Ag [Presence] in Serum

110

1.64

1.25

1.9

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

627

1.25

1.5

1.3

36.8

36.9

0.01

421

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.03

1.24

1.1

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

835

0.79

1.24

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

338

2734

1.12

1.22

1.7

1.6

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.90

1.20

2.3

1.2

0.5

0.09

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.76

1.19

1.2

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

105

1.63

1.18

1.3

1.6

u/l

0.4

0.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

330

1.34

1.17

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

354

1.33

1.16

2.4

3.2

ng/l

39.1

133.5

3.29

114

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.06

1.15

2.8

2.2

mu/l

1.4

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

186

1.46

1.15

2.1

2.2

mmol/l

0.5

0.9

1.02

114

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

474

1.28

1.14

1.2

mg/l

68.0

24.6

0.28

345

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

247

1.39

1.14

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

709

1.22

1.13

1.6

1.7

ug/l

9.1

5.1

0.28

491

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

115

865

1.20

1.13

12.4

11.4

nmol/l

752.1

836.0

1.08

109

825

(3008116) Ketones [Moles/volume] in Urine by Test strip

459

1.28

1.13

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

420

1.29

1.11

6.9

7.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.71

1.11

32.0

12.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

256

1.38

1.11

1.1

—

(3019174) dRVVT (LA screen)

158

1.49

1.10

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1059

0.83

1.10

1.4

1.5

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.37

1.07

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

236

1.38

1.04

1.1

umol/24h

2.1

1.7

1.73

236

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

983

0.83

1.04

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

982

0.83

1.03

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

981

0.83

1.02

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

176

1.44

1.02

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

980

0.83

1.01

1.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.26

1.01

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

103

1.58

1.00

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.60

1.00

1.0

u/ml

0.1

0.6

0.84

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.97

0.98

1.0

1.1

titre

1714.3

1833.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

255

1.35

0.97

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

156

1.45

0.96

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

107

1139

0.85

0.95

1.1

—

(3042517) Benzodiazepines panel - Urine

112

1.53

0.95

1.3

2.8

—

(40762814) Titanium [Mass/volume] in Blood

488

1.24

0.94

2.4

2.3

ug/l

2.9

3.7

1.77

172

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

156

0.58

0.93

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.57

0.93

11.5

8.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

165

1.42

0.92

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

851

0.83

0.92

1.4

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.68

0.91

1.1

umol/24h

0.2

0.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

378

0.74

0.91

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

418

1.25

0.90

1.3

1.8

ug/l

1.7

2.5

1.90

242

(3005033) Fetal Nuchal fold Thickness US

819

0.83

0.90

1.4

—

(3022475) Manganese [Moles/volume] in Blood

121

1.49

0.90

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.49

0.89

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.08

0.89

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.08

0.89

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.08

0.89

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.08

0.89

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.08

0.89

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.08

0.89

2.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.47

0.89

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

607

1.20

0.88

1.9

1.6

iu/ml

—

270.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

129

1.47

0.88

1.5

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.90

0.88

1.1

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

174

0.62

0.86

1.0

—

(40768793) Breast Pathology biopsy report

570

4816

1.07

0.85

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

293

1.29

0.85

2.5

1.6

—

(3045716) Anion gap in Serum or Plasma

145

1146

1.14

0.84

2.9

2.3

mmol/l

8.4

9.2

1.45

849

(3047352) Trisomy 18 risk [Likelihood] in Fetus

822

0.83

0.84

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.67

0.83

1.2

1.4

nmol/l

229.9

529.3

3.46

(3003740) Influenza virus B Ag [Presence] in Specimen

271

2225

1.10

0.82

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

162

1.39

0.81

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

235

0.69

0.80

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

610

0.81

0.80

1.3

1.5

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.79

0.0

2.2

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

1.2

—

468.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

163

1.38

0.79

2.6

2.8

pmol/l

7.8

58.9

1.32

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

641

1.18

0.78

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.80

0.78

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

212

1727

1.11

0.77

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

219

1.32

0.76

2.9

2.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

404

1.23

0.76

1.1

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

235

1.31

0.76

1.1

1.0

ug/l

101.8

82.1

1.07

173

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.15

0.75

1.4

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.70

0.75

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

269

2221

1.09

0.75

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.80

0.72

1.0

1.4

mmol/24h

2.3

2.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

201

1640

1.11

0.72

1.1

u/ml

3.6

3.0

0.17

612

(3028271) Lactate [Moles/volume] in Capillary blood

479

4054

1.07

0.72

2.1

1.9

mmol/l

1.7

0.02

469

3955

(3018834) Bilirubin.total [Presence] in Urine by Test strip

105

1.46

0.72

2.1

3.8

—

0.0

—

(3035060) Mercury [Moles/volume] in Blood

1.96

0.71

1.2

2.0

nmol/l

7.0

16.8

—

(3018291) Platelet Ab [Presence] in Serum

1.75

0.71

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.75

0.71

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

172

1726

0.90

0.71

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

167

1.35

0.70

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

161

1301

1.12

0.70

3.8

3.7

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.88

0.69

1.8

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

600

5712

0.95

0.67

1.4

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

411

1.21

0.67

2.2

3.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.80

0.66

1.0

u/ml

0.4

0.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.55

0.65

1.8

2.4

ug/l

0.1

0.23

(3015076) Soybean IgE Ab [Units/volume] in Serum

656

1.16

0.63

1.0

u/ml

0.4

1.1

0.40

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.53

0.62

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.67

0.61

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

253

1.25

0.59

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.58

0.0

1.6

—

18.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

292

2454

1.07

0.58

1.2

mmol/l

7.4

7.6

0.43

215

1756

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

123

996

1.11

0.56

1.2

63.7

58.5

0.19

109

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

123

996

1.11

0.56

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

196

1627

1.09

0.54

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

314

1.21

0.54

1.4

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.48

0.53

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

389

1.18

0.53

1.4

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

144

1.32

0.53

1.0

1.2

—

(3016228) CD19 cells/100 cells in Blood

113

915

1.11

0.52

2.0

8.4

0.00

108

889

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

106

1.36

0.50

1.1

1.0

—

(3013762) Body weight Measured

1.50

0.50

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

536

1.15

0.49

1.1

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

161

0.73

0.48

2.8

3.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

147

1.29

0.47

1.9

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

160

0.73

0.47

5.7

6.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

180

1.25

0.46

1.3

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.38

0.45

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

u/ml

0.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.44

0.43

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

561

1.13

0.42

1.9

1.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.39

0.41

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

208

1.21

0.41

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

129

1071

1.09

0.40

5.1

u/ml

70.6

4612.6

0.70

181

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

792

0.90

0.40

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

168

1.24

0.39

1.1

1.0

u/ml

0.2

0.6

0.36

124

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.41

0.38

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.41

0.38

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

108

892

1.09

0.38

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

642

1.11

0.38

1.2

—

(4133840)

541

1.12

0.37

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

113

1.28

0.36

1.1

mmol/l

8.6

0.06

113

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.34

0.35

1.4

1.1

mg/l

0.1

0.43

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

154

1.23

0.35

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

138

1.24

0.35

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.37

0.33

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.32

0.33

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

206

1757

1.06

0.33

1.1

u/ml

2.5

3.1

0.25

659

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

544

0.90

0.32

2.0

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

173

1.20

0.32

2.7

2.5

—

(3046861) Legionella sp Ag [Presence] in Urine

149

0.79

0.31

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

799

1.08

0.31

1.1

99.2

97.4

0.21

623

(40760410) HLA-B [Type] by High resolution

1.35

0.31

1.0

—

(40760409) HLA-A [Type] by High resolution

1.35

0.31

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.35

0.31

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

178

0.81

0.31

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

116

1.24

0.30

1.1

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.29

0.30

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.31

0.29

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

633

0.91

0.28

1.1

—

(44806071)

243

1.15

0.28

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

526

1.10

0.28

2.5

2.4

mmol/l

7.8

7.5

0.24

320

(3013293) Extractable nuclear Ab [Presence] in Serum

349

0.88

0.28

1.5

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

207

1959

0.95

0.27

1.6

1.5

—

(3013862) HLA-DP [Type]

1.31

0.26

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

110

1.23

0.26

1.2

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

194

1.16

0.26

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

152

1448

0.95

0.26

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.70

0.26

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.69

0.26

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

169

1.17

0.26

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

591

0.92

0.25

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

591

0.92

0.25

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

591

0.92

0.25

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

591

0.92

0.25

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

280

1.13

0.25

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

281

1.12

0.24

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

281

1.12

0.24

1.4

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

382

0.90

0.24

1.3

1.4

mmol/l

8.5

8.7

0.15

220

(3002719) Hemoglobin [Mass/volume] in Urine

1.33

0.23

1.0

1.1

—

(4038314)

1.29

0.23

1.2

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.27

0.22

1.1

—

(3034614) HLA Ag [Interpretation]

1.22

0.22

1.4

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

167

1440

1.05

0.22

1.3

pmol/l

71.8

93.7

0.47

473

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

122

0.81

0.22

1.5

mmol/l

22.1

23.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

883

0.94

0.22

1.4

1.5

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

509

0.92

0.20

1.9

2.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

159

0.85

0.20

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

153

1441

0.96

0.19

1.5

—

(3000012) Reticulocyte production index

167

1447

1.04

0.19

1.4

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.15

0.19

1.0

1.1

4.2

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

140

1210

1.04

0.18

1.5

4.7

3.8

0.34

258

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

107

1.18

0.18

1.1

1.0

u/ml

0.0

0.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

141

1.15

0.18

1.7

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

175

1524

1.04

0.16

1.9

1.6

umol/l

77.2

70.5

—

105

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.16

0.16

1.3

1.1

mmol/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2239

20379

0.99

0.16

4.8

3.9

mmol/l

1.2

1.23

2019

17680

(3022806) Fractional oxyhemoglobin in Capillary blood

371

3272

1.02

0.16

2.0

1.8

88.9

89.4

0.70

366

3224

(3012565) Volume of 24 hour Urine

141

1225

1.04

0.15

2.3

2.2

1893.1

1925.4

0.12

132

1061

(40758292) HTLV I+II Ab panel - Serum

333

0.92

0.15

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.18

0.15

1.0

u/ml

0.1

0.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

213

1.10

0.14

1.5

1.4

—

14.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

238

0.91

0.13

2.2

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

857

1.04

0.13

1.1

u/ml

25.5

11.6

—

(3035933) Granulocytes/100 leukocytes in Blood

437

1.05

0.11

1.2

1.8

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.13

0.10

1.0

1.4

e6/l

22.2

40.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

227

1.07

0.09

5.7

5.5

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.03

0.09

1.0

1.4

—

1742.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

263

1.06

0.09

2.4

3.1

mg/l

1.1

1.2

0.21

197

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

158

0.91

0.08

1.2

2.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

672

0.97

0.08

1.2

18.5

25.8

0.40

105

(3009677) Dengue virus Ab [Presence] in Serum

1.07

0.08

1.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.04

0.08

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.81

0.07

1.2

1.0

u/ml

0.2

0.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

469

0.96

0.07

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

368

0.96

0.07

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

505

0.96

0.07

1.4

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.12

0.06

1.0

—

(3003577) Lead [Moles/volume] in Blood

133

1.09

0.06

1.1

1.3

umol/l

0.1

0.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.84

0.06

1.0

1.2

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

100

0.90

0.06

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

228

2031

1.01

0.05

1.4

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

607

1.03

0.05

2.6

2.4

nmol/l

142.9

148.6

0.11

523

(40763480) Human metapneumovirus Ag [Presence] in Specimen

117

1.08

0.05

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1190

0.99

0.04

1.5

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

439

1.03

0.04

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

100

1.08

0.04

1.0

u/ml

0.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

262

1.03

0.03

1.1

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

271

1.03

0.03

5.7

8.0

umol/l

0.3

0.4

0.34

243

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

307

1.03

0.02

1.9

3.3

umol/l

36.3

40.4

0.47

255

(4034850)

841

7609

1.00

0.02

13.6

10.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

159

1424

1.01

0.02

1.0

u/ml

0.2

0.5

1.12

323

(3039443) Prostate specific Ag panel - Serum or Plasma

439

3975

1.00

0.02

1.6

1.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

102

1.06

0.01

1.0

u/ml

0.0

0.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

839

7585

1.00

0.01

1.6

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

264

1.03

0.01

9.1

10.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

131

1174

1.01

0.01

1.3

g/l

1.5

0.64

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

705

6350

1.00

0.01

1.7

mg/l

4.1

3.5

0.56

547

4558

(3051101) Glucose [Moles/volume] in Cord blood

472

1.01

0.01

4.6

6.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

175

1.03

0.00

1.4

1.8

0.4

0.8

1.24

138

(3027570) Oxalate [Moles/time] in 24 hour Urine

119

0.99

0.00

1.3

1.4

umol/24h

325.2

338.1

0.07

119

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

176

1.03

0.00

1.7

1.4

22.7

41.3

1.33

111

(3029396) Erythrocyte agglutination [Presence] in Blood

156

0.98

0.00

2.3

2.2

—

(3001729) Color of Synovial fluid

210

0.99

0.00

1.4

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

562

1.00

0.00

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

768

1.00

0.00

2.0

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

452

1.00

0.00

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

509

0.99

0.00

1.3

1.4

—

(40758358) Immune stain study

107

1.01

0.00

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

267

1.01

0.00

1.2

1.1

u/ml

82.8

62.2

0.69

256

(40768795) Lymph node Pathology biopsy report

261

2357

1.00

0.00

1.2

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.88

0.00

1.0

—

12217.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.8

—

3.4

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

13.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.86

0.00

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.00

0.00

2.0

2.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_COLORECANI and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLORECANI	1.236 [1.14, 1.34]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.223

During the follow-up period (1.1.1998 — 31.12.2019), 14200 out of 66651 females with CD2_BENIGN_COLORECANI died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLORECANI	1.328 [1.21, 1.45]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 19311 out of 66453 males with CD2_BENIGN_COLORECANI died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_COLORECANI.

N-year risk	Females	Males
1	0.104%	0.227%
5	0.658%	1.578%
10	1.776%	3.844%
15	3.638%	7.17%
20	6.368%	12.114%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLORECANI – Benign neoplasm of colon, rectum, anus and anal canal

GWS hits: 33

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm of colon, rectum, anus and anal canal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints